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ABSTRACT
MECHANISM OF THE HYDROXYLATION REACTIONS CATALYZED BY 4HYDROXYPHENYLPYRUVATE DIOXYGENASE AND HYDROXYMANDELATE
SYNTHASE
by
Dhara D. Shah
The University of Wisconsin-Milwaukee, 2014
Under the Supervision of Dr. Graham R. Moran
4-Hydroxyphenylpyruvate dioxygenase (HPPD) and Hydroxymandelate synthase (HMS)
carry out highly similar complex dioxygenation reactions using the substrates, 4hydroxyphenylpyruvate (HPP) and dioxygen. HPPD catalyzes decarboxylation, aromatic
hydroxylation and substituent migration (NIH shift) in a single catalytic cycle to form
homogentisate

(HG),

whereas

HMS

catalyzes

decarboxylation

and

aliphatic

hydroxylation to give hydroxymandelate (HMA). Wild-type HPPD, HPPD variants and
HMS variants produce both native and non-native products. Based on this observation,
we have employed a product analysis method with HPP deuterium substitutions (ring or
benzylic) that reveal kinetic isotope effects from intermediate partitioning ratios. In this
study we offer evidence for the 1) oxygenation intermediates for HPPD and HMS
pathways and 2) mechanism of NIH shift in HPPD. Our data with ring-deutero HPP
suggest that the native hydroxylation reaction of HPPD to form HG occurs via a ring
epoxide intermediate whereas secondary normal KIEs with 3’,3’-diduetero HPP in HPPD
indicate that bond cleavage in the substituent shift step occurs via a homolytic biradical
mechanism (biradical). HMS variants show a small normal KIE with 3’,3’-diduetero
!

ii!

!
HPP, indicating displacement of a benzylic deuteron in the hydroxylation step which has
a multiplicative component from geometry changes for the non-abstracted deuterium.
When R-3′-monodeutero-HPP is used as a substrate for HMS reaction, the secondary KIE
observed indicates sp3 geometry at the benzylic carbon in the transition state for the
hydroxylation step.
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Chapter 1

4-Hydroxyphenylpyruvate Dioxygenase and Hydroxymandelate
Synthase: Two-substrate α-Keto Acid Dependent Oxygenases

!

!

!
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1.1 Introduction
Although oxygen reduction is thermodynamically favored, kinetically it occurs slowly.
This can be attributed to the spin-triplet ground state of the molecular oxygen, which has
to react with singlet-state biological molecules. Oxygenases catalyze formation of
reactive oxygen species from dioxygen and add one or both oxygen atoms to a specific
molecule. Oxygenases make the reduction of dioxygen rapid by utilizing a cofactor
(generally a metal ion with paramagnetic properties or an organic prosthetic group
capable of one-electron chemistry), which bridges the reaction of singlet-state molecules
with triplet-state oxygen. Fe(II) is the most commonly found cofactor utilized by
oxygenases. Among the non-heme Fe(II)-dependent oxygenases, α-ketoglutarate (αKG)
is the most prevalent source of electrons for dioxygen activation (1). These α-keto acid
dependent oxygenases (α-KAOs) utilize a ferrous ion and the oxidative power of
dioxygen to collectively perform an extremely broad set of chemistries throughout
secondary metabolism. Some examples are enzymes involved in protein modifications,
alkylated DNA/RNA repair, antibiotic biosynthesis, biosynthesis of plant products, lipid
metabolism and oxygen sensing (2). The majority of the α-KAOs utilize three substrates:
molecular oxygen, αKG, and a substrate that is specific to each enzyme. These enzymes
typically catalyze two half-reactions, initial decarboxylation of the αKG and then
oxidation of the specific substrate. Grouped within the α-KAOs family are two important
enzymes that require only two substrates; i.e., 4-hydroxyphenylpyruvate dioxygenase
(HPPD) and hydroxymandelate synthase (HMS). These sister enzymes accomplish the
fundamental catalytic chemistry observed in essentially all α-KAO family members
without requiring αKG. For these enzymes, the requisite α-keto acid is supplied from the

!
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pyruvate substituent of 4-hydroxyphenylpyruvate (HPP), the organic substrate common
to both enzymes. The decarboxylation half-reaction is thought to be largely equivalent in
HPPD and HMS, while the oxidation/hydroxylation half-reactions differ in
regioselectivity and complexity. HPPD induces oxidative decarboxylation of HPP
followed by aromatic hydroxylation and substituent migration (known as the NIH shift),
whereas HMS accomplishes only decarboxylation and aliphatic hydroxylation at the
benzylic carbon (Scheme 1.1).
OH
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OH
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!
Scheme 1.1 Reactions catalyzed by HPPD and HMS

OH
O

Hydroxymandelate

!

The ubiquity of the HPPD reaction has meant that it has been enlisted to participate in
important added roles in a variety of organisms. This has resulted in its inhibition having
unique significance in each kingdom of life and has become the basis for the
development of herbicides and therapeutics.

1.2 Natural Context
Both HPPD and HMS acquire HPP from the first step of tyrosine catabolism (Scheme
1.2), a pathway that comprises five enzyme activities common to essentially all aerobes
that yields acetoacetate and fumarate for use in energy-yielding metabolism (Scheme 1.2black structures).
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Scheme 1.2 Tyrosine catabolism. Reactions shown in black depict the typical steps of the tyrosine catabolism pathway. Reactions
shown in red are mammalian metabolic disorders. Reactions depicted in blue are from bacteria and archaea. Reactions in green occur
in photosynthetic organisms.
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HPPD catalyzes the committed second step of this pathway in which HPP is converted to
2,5-dihydroxyphenylacetate (homogentisate, HG) (3). It was believed that, HPP to
homogentisate conversion was catalyzed by two separate proteins until in 1957 Hager et
al., demonstrated that this transformation was in fact catalyzed by a single protein HPPD
(3). Since its discovery the HPPD reaction has generated a great deal of interest due to
the curious chemical transformation catalyzed, but also as inhibition of this chemistry has
unique important outcomes. The reason for this is that tyrosine catabolism metabolites
provide biosynthetic stocks for the production of various physiologically important
molecules that are unique in each kingdom. Examples are plastoquinone and tocopherols
in photosynthetic organisms (4), melanin in fungi and bacteria (5), and cofactor F420 in
mycobacteria and archaea (6). A relatively new branch from tyrosine catabolism was
identified with the discovery of a protein having a similar sequence to that of HPPD, but
that acted only on the pyruvate substituent of HPP (Scheme 1.1) to form 4hydroxymandelate (HMA) (7). It transpired that this enzyme, HMS, catalyzes the initial
step in the biosynthesis of 4-hydroxyphenylglycine, a building block of various peptide
antibiotics (8).

1.2.1 Role in Photosynthesis
!In 1968, Hellyer et al identified oils secreted from 24 plant species that contained
leptospermone, a 1,3,3’-triketone that is secreted as an allelopathic agent (9). Usnic acid
is a second example of a naturally occurring molecule that has this triketone arrangement
and also serves to inhibit plant growth (Scheme 1.3A). Plants exposed to these
compounds produce chlorophyll and carotenoids in decreased amounts that results in

!
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bleaching and necrosis and eventual death (9-13). Synthetic derivatives based on the
leptospermone scaffold have brought new and more effective herbicides (Scheme 1.3). It
was initially believed that these triketones blocked carotenoid biosynthesis pathway by
inhibiting phytoene desaturase. It was later discovered that rats fed with the synthetic
triketone, NTBC, showed increased levels of tyrosine in blood and HPP in urine. This
indicated a negative influence in the tyrosine catabolism pathway. Later studies
established that NTBC blocked the first committed step of tyrosine catabolism inhibiting
HPPD (14). In early 2000, the mode of action for a natural triketone - usnic acid was also
confirmed to be HPPD inhibition (11). Since then this observation has been validated
with both in vivo and in vitro inhibition of plant derived HPPDs by various triketone
inhibitors (14). In photosynthetic organisms the HPPD reaction provides HG for the
biosynthesis of plastoquinone (a redox cofactor that bridges the photosystems), and
tocopherols (antioxidant lipophilic plant hormones) (15); HPPD is therefore required for
photosynthesis. 2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) was
one of the earliest synthetic HPPD herbicides identified and has remained the paradigm
HPPD inhibitor despite never being marketed for agricultural use (vide infra) (14).
Sulcotrione, mesotrione, isoxaflutole, and tembotrione are a few examples of highly
successful pre- and post-emergent broadleaf herbicides that target HPPD.

!

!

7!

A

usnic acid

leptospermone
O

O

O

O

sulcotrione

NTBC

HO

O

NO 2

O

O

Cl

O

OH
O

O

O

NO 2

O

O

CF3

O

isoxaflutole

mesotrione
O

O

HO

O

SO2CH3

O

tembotrione
O

SO2CH3

CF3

Cl

O

O
O

C

SO2CH3

CF3

O

SO2CH3

N
Y

B

Y

O

H 2O

Fe(II)

H O
OH 2

inhibitor
OH 2

H 2O

Fe(II)

e 450 = 450 M -1cm-1
O

O

X
OH 2

Y

e 450 = 300 M -1cm-1

O
OH 2

2H2O

B:
H 2O

X
H O

Fe(II)

H+
O

X
BH
H 2O

O

O

Fe(II)

inhibitor

!
Scheme 1.3 (A) Examples of HPPD inhibitors. Molecules in blue are naturally occurring.
NTBC, in red, is used for therapeutic purposes. Inhibitors shown in black are the active
components of commercially available herbicides. (B) A minimal kinetic mechanism for
association of inhibitors with HPPD.
1.2.2 Role in Mammals
In mammals tyrosine catabolism is required to diminish blood concentrations of
this highly insoluble amino acid. Five inborn errors of tyrosine catabolism result in
metabolic disorders (Scheme 1.2, red structures). Type II tyrosinemia is caused by a lack
of tyrosine aminotransferase activity. Elevated blood tyrosine levels are observed in
patients with this disease resulting in mild intellectual impairment, corneal opacities, and
palmoplantar hyperkeratosis (16). Mutations in the gene encoding HPPD cause type III
tyrosinemia and hawkinsinuria. Type III tyrosinemia, arises from mutations that render
HPPD inactive. Due to the reversibility of the tyrosine aminotransferase reaction, this
leads to elevated blood tyrosine and large excretion of tyrosine derivatives in urine (17).
!

!

8!
As such, patients with type II and type III tyrosinemias have similar pathologies. Type III
tyrosinemia is an autosomal recessive disorder because one of the alleles would produce
functional HPPD and only a homozygote would show clinical symptoms. Hawkinsinuria
results from a specific mutation in the gene coding for HPPD that expresses an active
enzyme that catalyzes an abortive reaction (17,18). This disease is thought to be an
autosomal dominant disorder, as only one mutated allele is required for the symptoms of
the disease to manifest. This disease is characterized by quiescence and a general
inability to thrive during infancy as a consequence of persistent acidosis, vomiting,
diarrhea, hair growth abnormalities and liver enlargement in some cases (19). Curiously,
the condition seems to self-correct at approximately two years of age for reasons that are
unknown (20,21). The disorder is diagnosed by the presence of hawkinsin in the urine. In
addition to hawkinsin, the unusual metabolites quinolacetic acid (QAA), 4hydroxyphenyllactic

acid,

4-hydroxyphenylacetic

acid

(HPA),

4-

hydroxycyclohexylacetic acid, and 5-oxoproline are also excreted (22). The causative
mutation for the occurrence of hawkinsinuria was thought to be an N-terminal alanine to
threonine change (A33T) from the case studies of two patients in early 2000 (17). This
was later shown to be a frequent polymorphism (23). Recently, the causative mutation for
hawkinsinuria was shown to be a missense mutation resulting in an Asn to Ser variant
(N241S in human HPPD) (18). This Asn is conserved in HPPD primary structure and the
mutation at this position was later explored with the structurally equivalent Rattus
norvegicus N241S HPPD and Streptomyces avermitilis N245S HPPD variants. In place
of HG, the variant enzymes form QAA that is prone to react via a Michael addition with
cellular thiols to form a two-electron oxidized form of hawkinsin (Scheme 1.2) (24-26).
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In this abortive reaction of HPPD, oxidative decarboxylation and ring hydroxylation
occur efficiently but the shift reaction does not occur resulting in the dissociation of a
premature product, QAA. HPPD variants with this mutation are subject to NTBC
inhibition in a similar manner to wild-type HPPD, suggesting a role for HPPD inhibitors
as therapeutics for hawkinsinuria patients (24).
Alkaptonuria is the oldest known inherited metabolic disorder. In 1902, Garrod
coined the term ‘inborn error of metabolism’ and speculated that alkaptonuria is caused
by inactivity or deficiency of the enzyme involved in the cleavage of the HG aromatic
ring (27,28). In 1958, La Du et al. established the deficiency of homogentisate 1,2dioxygenase (HGD) activity, the third enzyme in the tyrosine catabolism pathway, in the
manifestation of the disease (29). Patients with alkaptonuria excrete dark, melanin-laden
urine arising from the oxidation and polymerization of HG. These pigments also
accumulate in tissues where they cause ochronosis, a darkening of cartilage and bones,
and lead to arthritic joint destruction and deterioration of cardiac valves (30). HPPD
inhibition by NTBC has been tested successfully as a therapy for alkaptonuria patients,
causing pronounced abatement of symptoms (30-32).
The fourth step of the tyrosine catabolism pathway is catalyzed by
maleylacetoacetate isomerase. Any deficiency in the activity of this enzyme is not
deleterious as maleylacetoacetate can be converted to fumarylacetoacetate and
succinylacetone via a glutathione-mediated nonenzymatic bypass (33), and both of these
molecules are reported as substrates for the last enzyme in the pathway,
fumarylacetoacetase. The most severe and morbid tyrosinemia is type I. The primary
pathological signature is early onset of liver cirrhosis, renal tubular defects and ultimately

!
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hepatocellular carcinoma (34). Type 1 tyrosinemia is caused by the deficiency of
fumarylacetoacetase activity. As such, fumarylacetoacetate accumulates and leads to the
formation of succinylacetoacetate and succinylacetone, which have been linked with liver
and kidney damage possibly due to facile reactions with cellular thiols (35). Liver
transplantation was once the only effective therapy to treat patients with type I
tyrosinemia (36); however, in 1977 inhibition of HPPD activity was suggested as an
alternative approach (35). Patients treated with NTBC for several months show a marked
decrease in the plasma succinylacetoacetate and succinylacetone concentrations and
improved liver function. These initial trials established the current era of FDA approved
herbicidal treatment of type I tyrosinemia (37).
In summary, inhibition of HPPD by NTBC has provided established or potential
therapies for three of the five inborn errors of tyrosine catabolism. The therapeutic use of
NTBC, however, can lead to type II and III tyrosinemia-like symptoms including high
blood tyrosine levels, which can result in corneal opacities and suppression of IQ (38-40).

1.2.3 Role in Microorganisms
In Scheme 1.2, the blue reactions represent tyrosine catabolism branches that are
known to occur in bacteria and archaea. These branches function in pathogenesis, redox
reactions (coenzymes), and competition (antibiotic production). It was in this latter
function that HMS was discovered (7,8). HMS diverts HPP from the tyrosine catabolism
pathway and catalyzes the first step in the biosynthesis of 4-hydroxyphenylglycine. Based
on the sequence similarity of HMS to HPPD, it was hypothesized that HMS might be
involved in the biosynthesis of 4-hydroxyphenylglycine. The incubation of this protein
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with the substrates for HPPD showed 4-hydroxymandelate as a product and not
homogentisate and thus was named 4-hydroxymandelate synthase (8). The early labeling
studies confirmed that tyrosine was incorporated into the 4-hydroxyphenylglycine
structure of vancomycin (8,41). In 2000, Hubbard et al studied the four activities that
comprise the pathway for the formation of 4-hydroxyphenylglycine in the
chloroeremomycin biosynthetic cluster of Amycolatopsis orientalis (Scheme 1.4). The
first activities yield 4-hydroxyphenylpyruvate from both prephenate and tyrosine via
respective dehydrogenase and aminotransferase activities. 4-Hydroxyphenylglycine is a
non-proteinogenic amino acid and a substructure for many macrocyclic non-ribosomal
peptide antibiotics including vancomycin, complestatin, and chloroeremomycin.

OH
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Scheme 1.4 The metabolic cycle for the formation of 4-hydroxyphenylglycine (7)
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In another synthetic branch that occurs in mycobacteria and methanogenic
archaea, HPP is diverted from tyrosine catabolism and condensed with a pyrimidine
dione to form FO, the redox active portion of cofactor F420 (42,43). F420 is a cofactor
for F420 dependent glucose-6-phosphate dehydrogenase in mycobacterium species,
whereas in archaea it is necessary for the reactions catalyzed by hydrogenase, formate
dehydrogenase,
dehydrogenase,

methylene-tetrahydromethanopterin
methylene-tetrahydromethanopterin

dehydrogenase,
reductase

and

alcohol
quinone

oxidoreductase (44). Numerous pathogenic bacteria (e.g. Legionella, Shewanella, and
Pseudomonas spp.) are known to produce pyomelanin to aid virulence, and HPPD has
been identified as the virulence factor associated with pigment production (45). It is
believed that HG oxidation and polymerization yield pyomelanin and that this overproduction is selected for when the bacterial population experiences environmental
stresses such as the oxidative onslaught brought on by the immune system (46). In
clinical isolates from cystic fibrosis patients with persistent P. aeruginosa infections,
bacteria exhibit increased extracellular pyomelanin production resulting from mutation in
the HGD gene (47). Increased pyomelanin production is linked to the increased
persistence of infecting bacteria (5,48). Another study on P. aeruginosa showed a
development of small diverse subpopulations inside the biofilm. One of these
subpopulations produced increased pyomelanin, which may be a structural component of
the biofilm (49). B. cenocepacia is an opportunistic pathogen for cystic fibrosis (CF)
patients. This bacterium targets lungs of CF patients and causes persistent inflammation,
deteriorates the lung function and in extreme cases, develops a sepsis-like syndrome. This
infection causes increased inflammatory response to produce large quantities of reactive
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oxygen species in CF patients. B. cenocepacia producing increased pyomelanin is known
to survive in phagocytic vesicles within macrophage cells by scavenging free radicals
with the aid of pyomelanin. HPPD inhibition through NTBC, however, causes reduced
pigment production and increases clearance of pathogens by macrophages (50).
Tyrosine catabolism and HPPD have been linked to the establishment of specific
fungal infections. For the fungus Paracoccidioides brasiliensis the mycelium-to-yeast
morphological transition occurring inside the pulmonary epithelium is crucial to
establishing the infection in humans. HPPD is overexpressed during this transition, and in
vitro studies demonstrate that NTBC prevents the change in morphology and halts
infection, opening a door to the treatment of dimorphic fungal infections by HPPD
inhibition (51).
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1.3 Structure

Figure 1.1 Primary structure sequence alignment of C-terminal domains of HPPD and
HMS. HPPD and HMS sources for this study are highlighted in red. Conserved residues
are highlighted in yellow, residues that are either only conserved in HPPD or HMS
(distinct residues) are highlighted in green. The residues targeted for mutation in this
study have been indicated with blue stars.

HPPD is found in almost all aerobic life forms, whereas HMS is found only in
specific bacteria. Moreover, organisms that express HMS also express HPPD. These
factors suggest that the gene encoding HPPD is the progenitor of that for HMS. HPPDs
from bacteria are generally found as tetramers as opposed to mammalian HPPDs, which
!
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are dimeric in nature. Secondary structural elements of HPPD and HMS are highly
superimposable (Figure 1.3A) despite modest (~35%) sequence identity (Figure 1.1).
Both enzymes contain two structural domains, a conserved C-terminal domain that
includes all residues of the active site plus the ferrous ion cofactor and a less well
conserved N-terminal domain with apparent vestigial structural functionality (52,53).
Plant HPPD sequences are found to contain an insertion at carboxy terminus (54,55). The
N- and the C-terminal domains of each enzyme are also largely superimposable.

Figure 1.2 Topology of the vicinal oxygen chelate fold. Two βαβββ units are depicted.
β-strands are presented as arrows (dark gray) and α-helices are presented as cylinders
(light gray). In the middle of two βαβββ units, is a metal ion. The positions of residues
chelating metal ions from different β-strands have been depicted as lines. This figure has
been regenerated from reference (56).
Each domain forms an incomplete β-barrel comprised of tandem βαβββ units.
This overall bi-symmetrical topology suggests two successive gene duplications were
required to form the overall structure. This domain topology is that of the vicinal oxygen
chelate fold (Figure 1.2) (56,57), which has no topological resemblance to the structures
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of other α-KAOs that have modifications to the more common jelly roll fold (58). This
difference in topology indicates separate evolutionary lineages that yielded independent
mechanistic convergence.

Figure 1.3 (A) Superimposed tertiary structures of P. fluorescens HPPD (cyan, PDB ID:
1CJX) and A. orientalis HMS (yellow, PDB ID: 2R5V). (B) Unique and mechanistically
important residues, including the facial triad, in the active site of HPPD and HMS, with
substrate HPP modeled. The positions for the substrate were taken from reference (53).
As might be expected the majority of sequence conservation in HPPD and HMS
occurs in the catalytic C-terminal domain (Figure 1.1) and that many of these conserved
residues extend inward toward the approximate center of the β-barrel structure, arrayed
toward the metal ion (Figure 1.3B). Three of these residues comprise a common
structural motif, coined the 2-His-1-carboxylate facial triad, that is present in almost all
known mononuclear non-heme Fe(II)-dependent oxygenases (59,60). This motif, which
functions in coordinating Fe(II), has the general spacing of HX(D/E)X50-210H in αKGdependent oxygenases, whereas in HPPD and HMS a spacing of HX~80HX~80E is
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observed, consistent with their very different structures (2). The N-terminal domains in
both enzymes show few conserved residues as compared to the C-terminal domain. These
conserved residues are thought to be useful in connecting secondary structures for proper
folding of the polypeptide chain. The protein surface does not show any conservation of
residues in domains in either enzyme or between enzymes (52,53,56).

1.3.1 The Active Site
As might be expected, HPPD and HMS have numerous active site residues in
common; equally expected is that they possess residues that are conserved in only HPPD
or HMS sequences (Figure 1.1) (53). The structural conservation and the similarity of the
reactions catalyzed has been the basis of attempts to interconvert HPPD and HMS by
directed mutation (61,62). Figure 1.3B shows a select group of residues (conserved and
distinct in these structures) that have been the primary focus of hydroxylation
regiospecificity studies. In this figure, HPP is modeled into the substrate-binding pocket
to provide reference. This position for the substrate is based on the density observed for
HMA in the HMS•Co(II)•HMA structure, as no structure of the HPPD or
HMS•Fe(II)•HPP complex has yet been solved (53). While mutational studies have
helped elucidate the chemical mechanisms of HPPD and HMS (vide infra), few active
site residues have been assigned an unambiguous discrete catalytic function (24,61-64). It
was also observed that residues within the 10 Å distance of a metal ion in the active site
of HPPD and HMS make few ligand interactions and seem to have auxiliary indirect
functions (53). In HMS, a catalytic tolerance to mutation is observed; i.e., variants of
HMS with alterations to residues hypothesized to play a key role in catalysis and/or
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hydroxylation regioselectivity do not exhibit substantially altered catalytic chemistry. The
HPPD reaction coordinate, however, proved less durable in that active site variants are
observed to frequently uncouple in turnover and accumulate non-native products from
abortive pathways. This difference in response to mutation has been suggested to be a
consequence of the larger active site cavity in HPPD (~60 Å3 vs 30 Å3) whose shape
confines the phenol ring to a lesser extent than that of HMS (Figure 1.4) (53).

Figure 1.4 HPP modeled into the substrate-binding pocket of HPPD and HMS. The
shape of the active site cavity is shown for both. Substrate-binding pocket of HPPD is
shown in cyan and for HMS is shown in yellow. Residue numbering is based on the
HPPD from P. fluorescens and HMS from A. orientalis. The figure was regenerated using
the data from references (53,65).
A select number of α-KAOs have been investigated using magnetic circular
dichroism (MCD) spectroscopy to reveal the geometry about the Fe(II) (66-68).
Complexes with liganding α-keto acids typically exhibit low-lying metal-to-ligand
charge-transfer (MLCT) transitions arising from the coordination of the Fe(II) ion with
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the carboxylate and keto groups (66,69-71). Analysis of the near-IR MCD data for α-keto
acid dependent oxygenases indicate that resting enzymes show predominantly a sixcoordinate (6C) Fe(II) center (with three endogenous and three water ligands) which
remains 6C upon binding αKG, but switches to five-coordinate (5C) Fe(II) (with three
endogenous and two αKG ligands) upon binding of the specific substrate, thus opening
an attack site for dioxygen (66,72). The resting state HPPD/HMS•Fe(II) and
HPPD/HMS•Fe(II)•HPP complexes have similar MLCT transitions centered around ∼500
nm, characteristic of bidentate association of the α-keto acid moiety to the metal ion (7375). Analysis of the resting HPPD/HMS•Fe(II) complex shows a mixture of both 5C
(10%) and 6C (90%) ferrous ion geometry. Substrate bound forms of HPPD and HMS
largely retain this 5C:6C ratio, suggesting that for these enzymes predominant 5C is not
required to support their observed rates of reaction with dioxygen (69,76).
As stated above, no crystal structure of the HPP complex of either HPPD or HMS
has been solved. Similar bidentate Fe(II) coordination of HPP occurs in both enzymes,
but a curious reversal of transitions was noted in circular dichroism spectra of the
HPPD•Fe(II)•HPP and HMS•Fe(II)•HPP complexes (76). This result suggests unique
positions for the HPP phenol in the enzymes and promoted the notion that orientation of
the aromatic ring relative to the hydroxylating species is principally responsible for the
two observed activities (76). The structure of the HMS product complex,
(HMS•Co(II)•HMA), coupled with the shape similarities of HMA and HPP, aided
computer modeling of HPP into the active site of both enzymes (Figure 1.3B) (53). In the
modeled complex, HMS•Fe(II)•HPP, the 4-hydroxyl group of HPP is a hydrogen bond
donor to Ser-201, while in the HPPD•Fe(II)•HPP complex a 4.5 Å displacement of the 4-
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hydroxyl group allows it to act as a hydrogen bond donor to the amide group of Asn-216
and a hydrogen bond acceptor from Ser-201, simultaneously (53). This pivot of the
aromatic ring presumably dictates proximity of the benzylic carbon with respect to the
hydroxylating intermediate after decarboxylation. In HMS•Co(II)•HMA complex,
Thr214 exhibits an additional hydrogen bond with the newly added benzylic hydroxyl
group of the product HMA. This residue is only conserved in all HMS sequences. These
separate hydrogen bonding interactions in HPPD (Ser-201 and Asn-216) and HMS (Ser201 and Thr-214) may also contribute the different orientation of the reaction
intermediates in the active site and thus might be playing role in the regiospecificity of
the reactions catalyzed by HPPD and HMS. Density functional theory calculations
suggest unique conformations of the phenol are a result of differing conformations of
Ser-201 in the HPPD/HMS•Fe(IV)=O•HPA complex that then dictate the separate
reactivities (77,78).
As described in detail below, a pivot of the C-terminal α-helix in response to
inhibitor association suggests an active site gating function. All α-KAOs form highly
reactive oxygen species during the course of the catalyzed reaction. If these reactive
intermediates decay in an uncontrolled manner, the active site or external cellular
structures could incur oxidative damage (79). α-KAOs seem to employ a strategy of
sealing the active site with a variety of mobile secondary structures to confine the
chemistry and exclude the solvent from access to reactive species. Some examples are
mobile otherwise disordered loops in alkylsulfatase, proline 3-hydrogenase and
clavaminate synthase and α-helices in taurine dioxygenase, and HPPD (80-86). In HPPD,
this C-terminal helix has a number of disordered residues at the terminus. Truncation of
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these residues by mutation slows catalytic activity without affecting HPP binding. This
finding strongly suggests that these residues function to define the balance of open and
closed forms in solution (87).

1.4 Inhibition of HPPD and HMS
In terms of cumulative research activity, the catalytic chemistry of HPPD and
HMS has been partially eclipsed by the chemistry of HPPD inhibition. While both HPPD
and HMS are inhibited by 1,3,3’-triketones, only inhibition of the former has agricultural
and medical implications (vide supra) (88). With one exception (carrot HPPD (89)), all
other earlier inhibition studies for HPPD with triketone inhibitors for the measurement of
Ki and IC50 values came from crude enzyme preparations and with the assumption of
rapid single step binding and release. The corelation of IC50 and Kd is acceptable only if
these assumptions hold (90). Also for an irreversible inhibitor displaying a slow timedependent inhibition, IC50 value would not be helpful in determining the inhibition
potency. The reason being that the concentration of an active enzyme varies for any given
inhibitor concentration depending upon the pre-incubation time of enzyme-inhibitor
complex. Thus it is crucial to establish the kinetics of inhibitor interaction such that
conditions are selected that measure the true binding isotherm.
Despite clear herbicidal potency, one of the earliest inhibitors discovered, NTBC,
was not formulated for crop use due to the apparent complications of a long metabolic
half-life and limited long-term toxicity data. NTBC, nonetheless, remains the paradigm
HPPD inhibitor and has since been shown to have low toxicity and the pharmacological
advantage of an extended metabolic half-life (114). HPPD binds the exocyclic enol of
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NTBC, with the native ferrous state appearing to bind the inhibitor irreversibly (negating
the rapid equilibrium assumption used in IC50 determinations). While both HPPD•Fe(II)
and HPPD•Fe(II)•HPP complexes react with molecular oxygen, the HPPD•Fe(II)•NTBC
complex does not. This observation was confirmed with no loss in the MLCT transition
for HPPD•Fe(II)•NTBC complex over long incubation periods (91). This might be a
result of the blockage of the entry of molecular oxygen in the catalytic site of HPPD
because of the presence of NTBC. Using the kinetics associated with the development of
MLCT absorption transitions that arise in the inhibitor complex, a minimal three-step
kinetic mechanism for NTBC association was proposed (Scheme 1.3B) (91).

Figure 1.5 Bidentate association of HPP and NTBC to HPPD metal center. Similarity of
the available positions for Fe(II) coordianation for (A) HPP and (B) NTBC are depicted.
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The inhibitor made bidentate association with the active site metal ion to give
primarily five-coordinate, distorted square pyramidal complex (Figure 1.5B) (84). In the
first step NTBC binds weakly in a non-metal-centered complex. In the second step
association of NTBC to the metal ion is observed as an accumulation of MLCT
transitions centered about 450 nm. The final and slowest step is proposed to entail an
irreversible deprotonation of the exocyclic enol group of the inhibitor to form the enolate
complex with more intense MLCT at 450 nm (91). MCD spectra of the
HPPD•Fe(II)•NTBC complex indicate that, despite its apparent extremely high affinity
for HPPD, NTBC association with the active site Fe(II) is weaker than HPP association
with the metal ion by ~12 kJ/mol (92). As such, it was concluded that bidentate
association of the inhibitor to the active site metal ion (Figure 1.5) does not appreciably
contribute to the binding energy for the inhibitor complex. The interaction of NTBC with
the sister enzyme HMS from A. orientalis was explored later (88). The mechanism of
NTBC association with HMS differs only slightly from HPPD, in which three-charge
transfer species were observed for HMS•Fe(II)•NTBC complex after initial reversible
step. All three charge-transfer species observed in HMS depicted no spectrophotometric
difference except the change in the extinction coefficients at 450 nm. However in HPPD,
the last charge-transfer complex exhibits a very significant difference in the extinction
coefficient at 380 nm together with 450 nm. While the minimal kinetic mechanisms for
the association of NTBC to HMS•Fe(II) and HPPD•Fe(II) complexes revealed some
differences, both enzyme complexes with NTBC were equally unreactive to molecular
oxygen. This confirmed NTBC as an irreversible inhibitor for HMS (88).
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Figure 1.6 Structure of the HPPD•Fe(II)•NTBC complex. (A) The open C-terminal
domain of HPPD from S. avermitilis in complex with NTBC (cyan, PDB ID: 1T47)
overlaid with the closed position for the C-terminal α-helix from the P. fluorescens
HPPD structure solved in the presence of an acetate ligand (grey, PDB ID: 1CJX). (B)
The NTBC complex with the active site of HPPD. The residues shown are from the S.
avermitilis HPPD•Fe(II)•NTBC complex (cyan, PDB ID: 1T47) and are those that
contact the metal ion and/or the inhibitor. The displacement of the C-terminal α-helix is
indicated relative to the position observed in the closed structure from P. fluorescens
HPPD (grey, PDB ID: 1CJX).
The first inhibitor-bound HPPD structure reported was for S. avermitilis HPPD
crystallized in the ferrous oxidation state in complex with NTBC (84). This complex
reveals that the inhibitor makes the previously predicted bidentate interactions to the
metal ion via its 1-ketone and 3-enol moieties (Figure 1.5B). While the overall fold
reveals

a

high

degree

of

similarity

to

the

earlier

solved

P. fluorescens

HPPD•Fe(III)•acetate structure (52), the C-terminal α-helix was pivoted about its Nterminal end to a position that places it at a ~40° angle compared to the earlier observed
position (Figure 1.6). The other major difference between two structures came from the
different packing of the β-strands and the intervening turn (residues 130-143 in S.
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avermitilis HPPD, residues 106-116 in P. fluorescens HPPD) because of the increased
length of the β-structure and the different position of the adjacent turn (84).
The C-terminal α-helix includes Phe-364 that, in combination with Phe-336,
makes a staggered π-stacking interaction with the aromatic ring of NTBC (Figure 1.6B).
Other mammalian HPPD inhibitor complexes have been solved since that show similar
C-terminal α-helix displacement and stacking arrangements (55). Such π-stacking
interactions are typically very low-energy associations and unlikely to account for the
observed affinity. Since no additional electrostatic or hydrogen bonding interactions are
observed in the HPPD•Fe(II)•NTBC complex, the basis for the extremely high affinity is
largely unknown; however, it would appear that NTBC has excellent shape
complementarity and makes near uniform van der Waals contact with the active site
cavity (Figure 1.7) (65).

Figure 1.7 Active site residues in van der Waals contact with NTBC

!

!

26!
1.5 The Reaction Catalyzed
HPPD and HMS catalyze two half reactions, decarboxylation and a hydroxylation.
Decarboxylation half reactions in both are thought to be the same, while the
hydroxylation reactions diverge to form unique products. In the decarboxylation halfreaction dioxygen reduction occurs after HPP association, and oxidative decarboxylation
of the α-keto acid moiety yields the reactive Fe(IV)=O (ferryl) intermediate. There is
scant experimental evidence for the events of this half-reaction. What is known has been
assembled from computational studies and suggests that an Fe(III) superoxo species
attacks the α-keto carbon atom to initially form a bridged peroxo species that then
liberates carbon dioxide and forms a peracid intermediate. Severing of the peroxy bond
forms the highly electron deficient ferryl species coordinated to HPA. From this point the
hydroxylation half reaction ensues. As stated, it is thought that proximity dictates where
the Fe(IV)=O species will hydroxylate; in HMS, the benzylic carbon of HPA has greater
proximity, while in HPPD it is the aromatic C1 position, each as a direct consequence of
the position of the phenol moiety (Figure 1.3B).

1.5.1 The Mechanism of Decarboxylation
The decarboxylation half-reaction starts with ordered substrate binding, a
commonly observed feature in α-KAOs (1). For the three-substrate α-KAOs, the
catalytic cycle starts with the binding of αKG, followed by the addition of the specific
substrate to form a ternary complex that has heightened reactivity toward molecular
oxygen (70) as a consequence of the switch from 6C to 5C geometry at the metal ion
(66,72). HPPD and HMS also exhibit ordered substrate addition with HPP being the first
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substrate to bind followed by molecular oxygen. Relative to the HPPD/HMS•Fe(II)
complexes, the HPPD/HMS•Fe(II)•HPP complexes show reactivities towards molecular
oxygen that are several thousand fold more rapid (73,75). The basis for these changes in
reactivity appears to derive from the conformation of the HPP α-keto acid. The
absorption spectrum of unliganded HPP shows an n→π* transition at ~31,500 cm-1 that
shifts to ~28,000 cm-1 when bound in the active site of HPPD or HMS. The difference in
energy of the α-keto acid n and π* orbitals is evidence of the dihedral angle between the
carbonyl and carboxyl groups (θ) and this energy difference reaches a minimum when the
two groups are coplanar (Figure 1.3B) (66). The planar conformation of the α-keto acid
maximizes conjugation between the coordinating moieties and the ferrous ion, facilitating
metal to dioxygen charge delocalization. The energy of the n→π* transition of
HPPD/HMS•Fe(II)•phenylpyruvate complexes indicates flattening of the α-keto acid
only in HMS, consistent with the observation that phenylpyruvate is a substrate only for
HMS (77).
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Scheme 1.5 Common decarboxylation half reaction in HPPD and HMS
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The decarboxylation half-reaction is largely kinetically obscured in single
turnover reactions of HPPD and HMS. While an early intermediate can be observed to
accumulate to some extent, no evidence has yet been offered for the identity of this
species (73-75). Computational data have provided detailed descriptions of the possible
mechanisms for the decarboxylation chemistry (Scheme 1.5) (93-95). From such studies
it was proposed that the first step after addition of HPP is the stepwise reduction of
dioxygen to first form the ferric-superoxo species. Attack on the α-keto carbon forms a
Fe(IV)-peroxo bridged species that decays with concomitant release of CO2 to give a
ferrous peracid intermediate. This peracid then undergoes heterolytic cleavage of the
O−O bond to yield the E•Fe(IV)=O•HPA intermediate. In a variation of this sequence it
has also been suggested that the ferric superoxo species can decay to the peracid via a
single transition state (Scheme 1.5) (94). The Fe(IV)=O species accumulates in threesubstrate α-KAOs as the first intermediate concomitant with CO2 production (96-100).
The identity of the intermediate was revealed by Mössbauer spectroscopy in conjunction
with rapid freeze-quench, facilitated by enhanced accumulation of the intermediate that
occurs when a deuterium is substituted at the site of the hydroxylation (98-101).
Understanding the timing of the CO2 release, was attempted using 14C labeled substrate,
which did not clearly establish if the release occur before, after or together with
Fe(IV)=O intermediate (97). Fe(IV)=O is a highly electrophilic species that oxidizes a
variety of proximal centers and thereby can be used for a range of different chemistries
(1,2); however, the extreme electrophilicity of the ferryl species makes it unruly and
prone to hydroxylate nearby active site residues. This phenomenon of self-hydroxylation
has been observed in a variety of α-KAO type enzymes, including HPPD (102-104).
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For HPPD and HMS, multiple intermediates have been observed in rapid mixing,
single-turnover reactions (Scheme 1.6). The available data suggest that the ferryl species
does not accumulate in these enzymes due to the formation and decay of this intermediate
being fast relative to prior and later steps (73,74,105). Nonetheless, wild-type HPPD and
variants of both enzymes make HPA as one of the products in an abortive pathway,
consistent with a common decarboxylation half-reaction and indirectly implying the
presence of a ferryl species (24,63,64).

HPPD/HMS•Fe(II)•HPP + O2

k1

I

k2

II

k3

III

k4

HPPD/HMS•Fe(II)•HPP + HG/HMA

Scheme 1.6 Four-step model for the single turnover reactions of HPPD and HMS

1.5.2 The Mechanisms of Hydroxylation
The fate of the oxygen atom of the ferryl species defines the hydroxylation
reactions of HPPD and HMS. Compared to the α-KAOs, the HMS hydroxylation halfreaction is rather conventional. The available data are consistent with the ferryl species
abstracting a hydrogen atom from the benzylic carbon of HPA, forming an Fe(III)-OH
intermediate. This species is able to quench the benzylic radical formed in the initial
abstraction by transfer of •OH in a rebound reaction that restores the Fe(II) state of the
metal ion (Scheme 1.8). In contrast to HMS, hydroxylation of the relatively electron
replete aromatic ring of HPA by the Fe(IV)=O species of HPPD induces the quite
remarkable displacement of the aceto substituent to the adjacent ring C2 carbon. As such,
the overall hydroxylation/rearomatization half-reaction of HPPD is considerably more
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chemically intricate and numerous hypotheses, based on experiment and/or intuition,
have been put forward to account for the chemistry (Scheme 1.7) (3,62-64,94,106-108).
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Since the first observations of aromatic shift chemistry in the pterin-dependent
hydroxylases, there has been a debate over the participation of either a benzylic cation
(Scheme 1.7, structure 2) or a 1,2-epoxide (Scheme 1.7, structure 3) as the immediate
intermediate arising from oxygenation of an aromatic ring (109-112). However, this
narrow set of possibilities was presumably defined from precedent for ring oxygen
substitutions in organic synthesis studies. Hybrid density functional calculations were
used to explore a more extensive set of reaction paths for the attack on the ring C1 carbon
by the Fe(IV)=O species, where oxygen addition forms either a radical σ complex, a
biradical, an epoxide (arene oxide), or a benzylic cation (Scheme 1.7, structures 4,5,3 and
2) (94). In these calculations, the radical σ complex having the Fe(III) state is preferred
over the ring cation or the epoxide intermediate. In a separate study, the epoxide was
claimed as the first intermediate of the hydroxylation half-reaction based on the
accumulation of an oxepinone from turnover of an HPPD active site variant that was
thought to be a direct rearrangement of the product epoxide (62); however, it was later
shown that the oxepinone is actually derived from QAA that was rearranged by the
inclusion of trifluoroacetic acid during the HPLC identification (24).
Quite recently methodologies have been applied that successfully probe the
hydroxylation half-reactions of both enzymes. Directed active site variants of either
enzyme commonly induce some degree of uncoupling to form both native and non-native
products. This outcome has enabled the use of intermediate partitioning to measure
kinetic isotope effects (KIEs) on specific steps (63,113) (see chapters 2 & 3). The
products monitored were HG (decarboxylated, doubly oxygenated and rearranged), HMA
(decarboxylated and doubly oxygenated), HPA (decarboxylated and singly oxygenated),
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and QAA (decarboxylated and doubly oxygenated) (24,63). KIEs are derived from the
change in ratio of the products in the presence of a strategically placed heavy atom label,
the ratio of ratios thus providing the KIE (Figure 1.8).
k2
k1

Intermediate

k3

k4

D

E+P1

E+P 2

E+P 3

kobs = (P1/(P1+P2+P3))H
(P1/(P1+P2+P3))D

Figure 1.8 Intermediate partitioning kinetic isotope effect calculation.

Intermediate partitioning KIEs have provided direct insight into both the initial
oxygenation by HPPD and HMS and the ensuing NIH shift steps of HPPD. The KIE on
the initial oxygenation step of wild-type HPPD when ring deuterons are added to HPP
was an inverse value of 0.84, suggesting an sp2 to sp3 hybridization change. This
hybridization change is predicted only for the formation of a ring epoxide (63). The
ensuing NIH shift must then transiently severe the bond to the aceto substituent in either
a heterolytic or homolytic mechanism. The earliest evidence for the mechanism of NIH
shift came from the lack of scrambling or inversion at the benzylic carbon when 3’monodeutero HPP is used as a substrate, and this result was recently confirmed (64,107).
While this lack of scrambling is seemingly consistent with a heterolytic mechanism in
which the in-flight benzylic carbon is anionic (sp3) in character, it was later suggested by
calculation to be an inconclusive result. Borowoski et al. determined that the barrier to
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bond rotation to give scrambling is substantially greater than that for recombination and a
lack of scrambling cannot by itself be evidence of the mechanism for the shift. 3’,3’dideutero HPP yields a KIE of unity for wild-type and most variants of HPPD (64);
however, an N245S variant (corresponding to Asn-216 in Figure 1.3) gives a normal KIE
of 1.4 for the formation of HG, suggesting a late transition state moving to sp2 geometry
with this variant. It was therefore concluded that in wild-type HPPD the shift occurs via a
minimally advanced transition state toward a homolytic mechanism (64), consistent with
the earlier conclusions from computational studies (94).
Recombination of the aceto group with the aromatic ring forms a dienone
(Scheme 1.7, structure 6) that can rearomatize through tautomerization to yield HG. The
activation energy barrier calculated for this tautomerization indicates this process could
take place either within the enzyme or in solution (94). Single turnover studies of HPPD
(Scheme 1.6) have shown that the highly fluorescent HG product (Scheme 1.7, structure
7) forms as the third intermediate ahead of the rate limiting dissociation of the product,
indicating that rearomatization occurs within the active site. Moreover, the rate constant
for the formation of this signal exhibits a KIE of 1.7 when ring-perdeutero-HPP is used as
a substrate, consistent with a modest primary isotope effect for displacement of a
deuteron from the ring 2-carbon during rearomatization (74). Decay of the third
intermediate (Scheme 1.7, structure 7) is sensitive to deuterons derived from the solvent.
In HPPD (and HMS) the product release rate constant (k4) exhibits a solvent kinetic
isotope effect of ~2 suggesting a role for an active site base in product release (73,74).
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Scheme 1.8 Hydroxylation reaction in HMS depicting all possible intermediates. (A)
Evidence for the hydrogen atom abstraction in HMS with 3’,3’-dideutero HPP as a
substrate. (B) Evidence for the geometry of the remaining atom after initial H-atom
abstraction with R-3’-monodeutero HPP as a substrate.
Hydroxylation in HMS occurs at the benzylic carbon of HPA to give product
HMA. Unfortunately, substitution of a deuterium atom(s) at the benzylic position of HPP
does not slow any of the steps observed in single-turnover reactions of HMS (73). This
result suggests that the hydroxylation reaction of HMS is fast and unable to be observed
directly by conventional kinetic approaches. In HMS, the ferryl species abstracts only the
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pro-S hydrogen atom to form a ferric-hydroxyl species (73). This Fe(III)-OH then attacks
the benzylic radical via an oxygen rebound mechanism to form HMA (Scheme 1.8A).
Like HPPD, HMS variants also show product partitioning, but they form just two
products, HPA and HMA. When 3’,3’-dideutero HPP is used as a substrate, the
intermediate partitioning KIE is 2.2-2.6. This outcome suggests an H-atom abstraction
that is largely devoid of tunneling (63). The KIE measured with the dideutero substrate is
expected to include a multiplicative component from the non-abstracted deuteron
(Scheme 1.8A). To dissect each component, the equivalent experiment was carried out
with R-3’-monodeutero HPP and the KIE measured (Scheme 1.8B). This experiment
gave a KIE of 1.06 indicating little geometry change in the transition state during
abstraction (64). The F364I HPPD variant is able to form HMA as a product in 20% of
turnovers. The R-3’-monodeutero HPP substrate shows a KIE of 1.92 with this variant, a
significantly normal secondary effect, suggesting a hybridization change from sp3 to sp2
consistent with a less optimized reaction for the production of HMA in this variant.
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1.6 Concluding Remarks
HPPD and HMS are the outliers of the α-KAO family. While they catalyze a
mechanistically equivalent set of reactions to those observed in the majority of the
enzyme family, they have evolved independently and exhibit unique characteristics that
have in some cases elucidated parts of the catalytic cycle that remain obscured in all other
family members. The ubiquity of the HPPD reaction has meant that its inhibition has a
collectively broad set of consequences. Inhibitors have been found to be highly
successful herbicides, targeted therapeutics for in-born errors in tyrosine catabolism, and
have shown potential to augment the treatment of microbial infections.
For some considerable time there has been conjecture pertaining to the
mechanism(s) of hydroxylation reactions catalyzed by Fe(II) dependent oxygenases (109112). This chapter presented a summary and most up to date mechanistic chemistry of
HPPD and HMS. Parts of this chapter have been published as a chapter in a book titled 2Oxoglutarate-Dependent Oxygenases (Schofield C. J. and Hausinger R. P. Eds., In press).
Chapter 2 of this thesis provides an evidence for the participation of an epoxide as the
immediate intermediate with the oxygenation of an aromatic ring in HPPD. In the same
chapter we show that in HMS benzylic hydroxylation occurs with hydrogen atom
abstraction. This chapter was published as an article in Biochemistry (63). Chapter 3 of
this thesis focuses on defining the transition state geometries that arise during the NIH
shift in HPPD and hydrogen atom abstraction steps in HMS. From this chapter we
conclude that, NIH shift in HPPD occurs through homolytic mechanism and in HMS
hydrogen atom abstraction occurs without the geometry change at the benzylic carbon.
This chapter was published as an article in Biochemistry (64). Chapter 4 of this thesis
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details initial attempts to identify HPPD variants that have substantially altered kinetics in
order to reveal new parts of the catalytic cycle and define the function of active site
residues in HPPD.
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Chapter 2

Evidence for the Mechanism of Hydroxylation by 4Hydroxyphenylpyruvate Dioxygenase and Hydroxymandelate Synthase
from Intermediate Partitioning in Active Site Variants
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2.1 Introduction
Both 4-Hydroxyphenylpyruvate dioxygenase (HPPD) and hydroxymandelate synthase
(HMS) catalyze very similar dioxygenation reactions, even to the extent that they require
the same substrates, 4-hydroxyphenylpyruvate (HPP) and dioxygen (Scheme 2.1). With
respect to the reactions catalyzed, HPPD and HMS principally differ in the placement of
one of the atoms of dioxygen. For each, one oxygen atom is committed to an oxidative
decarboxylation that converts the pyruvate side chain to an aceto substituent. The other
oxygen atom is then added as a hydroxyl with HMS hydroxylating at the benzylic carbon
forming hydroxymandelate (HMA) and HPPD at the adjacent C1 of the aromatic ring.
Hydroxylation of the ring then induces a fascinating transformation involving a 1,2-shift
of the aceto substituent forming 2,5-dihydroxyphenylacetate (homogentisate, HG). !
HPPD is common to ostensibly all aerobes and is almost certainly the progenitor
of HMS that is found in a relatively small number of bacteria. The HPPD reaction is the
second step of tyrosine catabolism, a five-step pathway whose fundamental purpose is to
produce the energy-yielding products, fumarate and acetoacetate (1). However, pathway
intermediates can be drawn into the biosynthesis of other molecules (2-5). HMS
participates in one example of this, as it functions to divert HPP from tyrosine catabolism
to form HMA toward the biosynthesis of hydroxyphenylglycine that is incorporated into
a variety of non-ribosomal peptides such as vancomycin (6,7). Another example occurs in
plants where HG is the precursor to tocopherol and the critical photosynthetic cofactor,
plastoquinone. It is this that has, for the last three decades, garnered considerable research
interest in HPPD. Molecules that inhibit HPPD have potent herbicidal effects and a
number of such molecules are now sold worldwide as broad-leaf herbicides (8-10). An
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unexpected additional use for one of the molecules originally developed as a herbicide
has been as a therapeutic that can alleviate the symptoms of a number of in-born defects
in tyrosine catabolism (11-13). It could be argued that the study of the inhibition of
HPPD has eclipsed the study of its reaction mechanism and key details of the reaction
mechanism remain unsupported. Similarly, as it has only been described in the literature
recently, relatively little is known of the chemistry catalyzed by HMS (7,14).
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HPPD and HMS are Fe(II)-dependent dioxygenases that, from a chemical
standpoint, are grouped with the α-keto acid dependent oxygenases (α-KAOs) (15).
Structurally, however, both enzymes differ from the majority of α-KAOs that have a
jellyroll fold. Instead, HPPD and HMS have a topology that is common to the vicinal
oxygen chelate superfamily (16). α-KAO enzymes all obtain electrons to activate
molecular oxygen from oxidative decarboxylation of an α-keto acid. The most common
ensuing reaction of this group of enzymes is hydroxylation. HPPD is somewhat unusual
in that it hydroxylates an aromatic ring inducing the 1,2-shift of the aceto substituent
(Scheme 2.1). While shifts of this type have been observed in a number of oxygenases, it
is more common that only small substituents such as deuteriums, tritiums, halides and
methyl groups can be induced to shift in this manner and generally only in a fraction of
total catalysis (17-25). The identity of the intermediate that is the immediate product of
hydroxylation in such reactions has been the source of conjecture for more than 40 years.
The principle division is based around the intermediacy of an epoxide or a benzylic
cation. Either species can be readily envisaged to resolve as the final aromatic product
and experiments that unambiguously show one mechanism over the other have proven
exceedingly difficult to design. One definitive method to distinguish between these two
mechanisms is to measure the secondary kinetic isotope effect on the hydroxylation step
when a deuterium is substituted ortho to (or if applicable at) the point of hydroxylation
(26). However, in terms of direct observation or kinetic resolution, few if any of the
systems that exhibit an NIH shift are amenable to this observation. That is to say that the
hydroxylation rate constant cannot be measured with sufficient precision or else cannot
be observed independently due to the balance of rate constants for steps before and after
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(25,27-29). Moreover, this is a recurrent limitation in the study of many metal dependent
oxygenases, including for enzymes that carry out less complicated hydroxylation
reactions such as hydroxylation at aliphatic carbon atoms, as is the case for HMS. These
hydroxylation reactions exhibit primary kinetic isotope effects when deuterium atoms are
substituted at the point of hydroxylation (30) but these effects can also be completely
shrouded (31). The utility of intermediate partitioning and product analysis has emerged
as a robust and accurate method that can be used to unveil otherwise hidden kinetic
isotope effects (26,32-35). In this chapter we describe the application of this methodology
to variants of HPPD and HMS that exhibit bifurcation and trifurcation during the
hydroxylation step and as such yield multiple distinct products in a defined ratio (Scheme
2.1).
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2.2 Materials and Methods
Materials. HPP and HG were purchased from Acros Chemicals. HMA and 4hydroxphenylacetatete (HPA) were obtained from Sigma-Aldrich. Mutagenesis was
performed using the materials and protocol of the Stratagene QuikChange Lightning ®
kit. Competent BL21(DE3) Escherichia coli cells were obtained from New England
Biolabs. IPTG was from Gold Biochemicals. D2O was from Cambridge Isotope Labs. QSepharose was from Bio-Rad. Sephacryl S-200 was obtained from Amersham.
Quinolacetate (QAA) was made using the P243T variant described in this manuscript and
purified as previously described (13). Per-deutero-HPP and 3’3’-dideutero-HPP were
prepared according to our previously published methods (27,31). All other chemicals,
buffers, and biological media were obtained from Fisher Scientific or Sigma-Aldrich
Chemicals and were of high purity.

Mutagenesis. pET17b-derived (Novagen) plasmids carrying the Streptomyces avermitilis
HPPD gene (pSAHPPD; (36)) and the Amycolatopsis orientalis HMS gene (pAOHMS;
(37)) were mutated using the Stratagene QuikChange Lightning ® kit. Mutations were
identified in the transformants by either incorporating changes to the plasmid restriction
pattern by the addition of silent mutations or by sequencing the plasmid from multiple
transformants. In each case, sequencing the entire gene confirmed the desired mutations
and the absence of additional spurious mutations (Sequetech, Mountainview CA). The
following oligonucleotides and their respective reverse complement oligonucleotide were
used to mutate the HPPD gene(s):
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HPPD Oligos
SAHPPDN245I: GGTCAAGTTCCCGATCATCGAGCCCGCCCTGGCCAAGAAGAA
SAHPPDN245Q: CAAGTTCCCGATCCAGGAGCCCGCCCTGGCCAAGAAGAA
SAHPPDP243T:
CTCAAGGTCAAGTTCACGATCAACGAGCCCGCCTTGGCCAAGAAGAAGTCC
SAHPPDS230A:
GACATCGCGACCGAGTATTCGGCGCTGATGGCGAAGGTCGTGGC
HMS Oligos
AOHMSI216N: CACCCTCACCCTGAACGAGCCCGACCG
AOHMST214P: GCGGTCACCCTCCCGCTGATCGAGCCC
AOHMSS201A: CAGGCGATGAACGCCACCGTCGTGCAG

Expression and Purification. The apo-forms of WT and variants of HPPD and HMS
were expressed and purified using ammonium sulfate fractionation, anion exchange
chromatography and size exclusion chromatography according to published methods
(36,37).

Standard Assay Conditions and Steady-State Analysis. HPPD/HMS activity was
measured using a Hansatech Oxygraph dioxygen electrode. Standard activity assays
included 1-2 µM of enzyme, 1 mM β-mercaptoethanol (βME), 20 µM ferrous sulfate,
and 400 µM HPP in 20 mM HEPES pH 7.0 at 25 oC with atmospheric oxygen (250 µM).
Reactions were initiated with HPP, and rates were measured between 20 and 50 s of
initiation. Apparent kinetic parameters were measured by varying the concentration of
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HPP. Data were fit to the Michaelis-Menten Equation (equation 1).

equation 1.

v = Vmax [S]/(Km+[S])

Kinetic Isotope Effects from HPLC Product Analysis. The ratio of products of each
variant enzyme was determined using high-pressure liquid chromatography. Initially
enzyme turnover reactions were undertaken at 25 °C and were comprised of 25 µM
ferrous sulfate, 6-10 µM HPPD or HMS, 1 mM reductant (either βME or dithiothreitol),
250 µM O2, and 100 µM HPP in 10 mM potassium phosphate or 20 mM HEPES buffer
(pH 7.0). The initial background rate of dioxygen reduction due to Fenton chemistry was
observed before the enzymatic reaction was initiated by either the addition of unlabeled
or deutero-labeled HPP (ring-deutero for HPPD and 3’3’-dideutero for HMS). After
completion of the reaction (i.e, when the observed rate of dioxygen consumption
approximated that due to background dioxygen reduction), 400 µL of the reaction
mixture was withdrawn added to a 0.5 mL, 10 kDa nominal molecular weight limit ultra
centrufugal filter (Amicon) and centrifuged at 14000g for 7 min to remove the enzyme.
The resulting filtrate was chromatographed using a Waters 600E HPLC system fitted
with a 4.6 mm x 150 mm Waters 5 µm Xterra reverse phase C18 column. The column
was run under isocratic conditions at 1 mL/min with a mobile phase consisting of 10 mM
potassium phosphate (pH 2.0) and 0.5% acetonitrile. Elution was monitored at 220 and
276 nm using a Waters 2487 dual wavelength detector. Individual products were
identified by co-elution with standards for each. Quantitation was accomplished by
preparing standard curves from 0–100 µM for each product under the same conditions.
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Kinetic isotope effects were calculated using Equation 2 that computes the factor
of perturbation of the product ratio in the presence of the deuterated substrate for the case
of a trifurcating mechanism (35).

equation 2.

D

kobs = (P1/(P1+P2+U))H
(P1/(P1+P2+U))D

In this equation, P1 is the concentration of product for which the isotope effect is being
determined and P2 is the concentration of an alternate product formed in the same
reaction. For both HPPD and HMS, U refers to uncoupling in the hydroxylation step that
is isotopically insensitive and results in the production of HPA. For the case of
bifurcating reactions where two products are evolved the P2 term is omitted. To ensure
that all of catalysis was considered, the total consumption of molecular oxygen was
compared to the total concentration of products formed.
The KIE values for HG would be skewed if QAA were to act as a shunt substrate
for HPPD and converted to HG. In order to establish if HPPD can catalyze the conversion
of QAA to HG, 60 µM QAA was incubated with 15 µM HPPD in the presence of 25 µM
ferrous sulfate, 1 mM ascorbate in 10 mM potassium phosphate buffer pH 7.0. After
incubation at 25 oC for 10 min (approximately twice as the length of time used for the
KIE assays), 200 µL of the reaction was withdrawn, filtered and chromatographed as
above. The chromatogram obtained from this sample was then compared to the control
incubated in an equivalent manner in the absence of HPPD.
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2.3 Results
Characterization of the Variant Enzymes. Each of the HPPD and HMS variants
described could be expressed and purified using published methods for the wild type
enzymes (31,36). Moreover, the yield of purified enzyme was generally comparable to
the wild type forms and each could be stored at – 80 oC without appreciable loss of
activity. Apparent steady-state turnover values for each variant are listed in Table 2.1.
These values are not directly applicable to the conclusions made here but do indicate that
each mutation yields an active and competent enzyme.

Table 2.1 Steady-State Kinetic Values
HPPD Variant

WT

N245I

N254Q

P243T

S230A

6.8 ± 0.6

0.64 ± 0.09 0.03 ± 0.01 2.1 ± 0.1

2.8 ± 0.4

27 ± 6

27 ± 5

15.0 ± 3.3

8.7 ± 2.8

47 ± 16

254 ± 70

24 ± 6

2.4 ± 0.4

241 ± 36

60 ± 15

WT

I216N

T214P

S201A

3.7 ± 0.1

1.4 ± 0.1

1.18 ± 0.04

3.0 ± 0.6

47.6 ± 5.6

14.3 ± 3.0

20.5 ± 2.8

28.0 ± 13.5

77 ± 5

98.5 ± 14.5

57.5 ± 6.5

108 ± 19

-1

k

cat

K

(s )

HPP

(µM)
-1 -1

k /K
cat

HPP

(mM s )

HMS Variant
-1

k

cat

K

(s )

HPP

(µM)

k /K
cat

-1 -1
HPP

(mM s )

Product Analysis. The percentages of products formed by each variant of HPPD and
HMS are shown in Table 2.2 and the position of each residue in the active site is shown
in Figure 2.1. For each variant all major products were accounted for in that the
percentages of all products summed to ~100 % based on the uptake of dioxygen. This
indicates that for both HPPD and HMS, hydroxylation is tightly coupled to dioxygen
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reduction and that all reducing equivalents committed to catalysis result in substrate
decarboxylation.

Table 2.2 Percentage of Products Formed
HPPD
Variant
HG (%)
QAA (%)
HPA (%)
HMA (%)
Total
HMS
Variant
HG (%)
QAA (%)
HPA (%)
HMA (%)
Total

WT

N245I

N245Q

P243T

S230A

84.5
0
15.4
0
99.9

13
0
86.6
0
99.6

44.5
4
52
0
100.5

13
78
8.7
0
99.7

11.6
57.8
30.6
0
100

WT

I216N

T214P

S201A

0
0
0
100
100

0
0
10
90
100

0
0
0
100
100

0
0
12
88
100

None of the variants presented made any fraction of the product of the other
enzyme. In other words, HPPD variants were observed to make only HG, HPA and QAA,
while HMS variants made only HMA and HPA, indicating that the preference for
hydroxylation regiospecificity was not altered by these mutations. Under the conditions
used in this investigation wild type HPPD is prone to uncoupling to form HPA. This
suggests that the hydroxylation of the aromatic ring is less optimized than the
hydroxylation of the benzylic position by HMS, that is fully coupled to the formation of
HMA. For respective HPPD/HMS variants, alteration of the 245/216 position and the
230/201 position increases uncoupling in the hydroxylation reaction yielding more HPA
than is observed in the wild type of either enzyme (Figure 2.1).
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Figure 2.1 Positions of the residues targeted for mutagenesis. The positions are shown
for HPPD with residues and numbers in parentheses indicating the corresponding residue
in HMS. All three positions are clustered on the third and fourth β strands of the β-barrel
that is common to the vicinal oxygen chelate superfamily of enzymes. The putative 4hydroxyphenylpyuvate binding site was modeled in earlier work using molecular
dynamics and was based the observed binding position for hydroxymandelate in
hydroxymandelate synthase (37). In this position the 4-hydroxyl of the substrate phenol is
within hydrogen bonding distance to the conserved serine residue. The sections of amino
acid sequence shown compare the primary sequences of HPPD from Strepomyces
avermitilis and HMS from Amycolatopsis orientalis local to the residues altered by
mutation.
Interestingly, mutating to counterpart residues at the 243/214 positions resulted in
improved or equivalent hydroxylation efficiency. For HMS, this result is contrary to what
would be predicted from structure as threonine 214 is observed to hydrogen bond to the
newly added side chain hydroxyl in the HMS•HMA product complex, prompting the
proposal that this threonine may participate in the delivery of the oxygen to the benzylic
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carbon (37). P243 in HPPD clearly contributes an important steric component to the
execution of the NIH shift. Mutating this residue to threonine results in the majority
(~80%) of the hydroxylation reaction terminating with the formation of QAA; where the
hydroxyl has been delivered to the ring C1 without displacement of the aceto substituent
bonded in this position. The N245 position is also critically important in the NIH shift. In
previous work we have shown that mutation of this position to a serine residue results in
a predominance of QAA (13). Here, mutation to an isoleucine results in ~90%
uncoupling in the hydroxylation step and the formation of HPA. Curiously, the N245Q
and N245I variants were able to complete the shift for most instances in which they
hydroxylate the ring (~50%, ~10% respectively) and uncouple to make HPA for the
remaining fraction of total turnover. Together these results suggest that a hydrogenbonding residue in the 245 position aids the initial ring hydroxylation reaction and that
only in the presence of a large and/or amide side chain can the NIH shift occur.
The serine at position 230/201 is fully conserved in all HPPD and HMS primary
structures implying that it is vital in the mechanisms of both enzymes. This would appear
to be correct for HPPD that either uncouples or predominantly fails to execute the shift
when this residue is mutated to an alanine. However, S201A in HMS has a very modest
effect on the product distribution, causing the enzyme to uncouple in only ~10% of
turnovers, prompting the question as to why this residue is fully conserved in HMS
primary structure.
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Kinetic Isotope Effects from Hydroxylation Partitioning. The kinetic isotope effects as
measured from hydroxylation partitioning for both HPPD and HMS are listed in Table
2.3.
Table 2.3 KIEs from Isotopic Perturbation of Hydroxylation Partitioning
HPPD
Variant
D
kobs HG
replicates
D
kobs QAA
replicates
HMS
Variant
D
kobs HMA
replicates

a

WT

N245I

0.84 ± 0.01
3
n.m.a
3
WT
n.m.
1

1.02 ± 0.06
2
n.m.
2
I216N

a

2.19 ± 0.01
3

N245Q
0.99 ± 0.01
2
1.09 ± 0.08
2

P243T
1.05 ± 0.08
3
0.76 ± 0.04
3
T214P
n.m.
1

S230A
1.07 ± 0.10
2
1.02 ± 0.04
2
S201A
2.56 ± 0.24
3

not measureable.

In prior research we have shown using the isotopic substitutions of HPP used here, that
neither HPPD nor HMS accumulates the hydroxylating intermediate to any measureable
extent. The decay of this species is not limiting for any of the observed catalytic events
and as such simple isotopic substitution and kinetic investigation has not elucidated any
part of the early hydroxylation mechanism for either enzyme. This has limited our ability
to apply rapid mixing quench studies to characterize this step (27,31). As such, it is
assumed that the hydroxylating intermediate is an oxo-ferryl species as has been observed
in a number of mononuclear Fe(II) dependent hydroxylases (38-42). In Figures 2.2 & 2.3,
example HPLC chromatograms in the presence and absence of the isotopic label are
included to illustrate how these otherwise shrouded kinetic isotope effects were measured.
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Figure 2.2 Hydroxylation mechanism of HPPD as deduced from intermediate
partitioning. The proposed chemical mechanism of HPPD is shown. Molecules shown
boxed are detected as products. The origin of the kinetic isotope effects is shown as
italicized notations. Notations, P1, P2, and U refer to the variables of equation 2. The inset
depicts two chromatograms for P243T variant in the absence (solid line) and presence
(dashed line) of the ring-deuterium label of HPP.
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The kinetic isotope effects for HPPD indicate that multiple saddle points are
possible and that a variant enzyme may bias one of multiple pathways (Figure 2.2). As
stated, one of the unexpected observations was that the native form of HPPD exhibits
uncoupling to form HPA in a fraction of total turnover. The advantage of this is that it
affords the measurement of the secondary isotope effect associated with hydroxylation to
form HG for the native form of the enzyme. This value was 0.84 and strongly suggests
that an sp2 to sp3 hybridization change is occurring with the hydroxylation event. Such a
value is entirely consistent with the formation of a 1,2 ring epoxide during the
hydroxylation step and is the first direct evidence for the native mechanism of
hydroxylation by HPPD. Each of the variant enzymes investigated, however, show
kinetic isotope effects of 1 within error for the formation of HG which indicates either no
change in hybridization during hydroxylation, more consistent with the formation of a
benzylic cation or that multiple simultaneous pathways contribute to the effect. Similarly,
the KIE for the formation of QAA by the variants can be either inverse or unity indicating
that it is possible to yield this product via either of the proposed branches in Figure 2.2.
The native form of HMS is fully coupled in hydroxylation and forms only HMA.
As such the KIE for hydroxylation cannot be measured using partition analysis. This is
also true for the T214P mutation. Therefore we cannot observe the native function of the
enzyme by these methods. However, the kinetic isotope effect for hydroxylation by HMS
as it relates to mechanism is less disputed than is that for HPPD (Figure 2.3).
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Figure 2.3 Hydroxylation mechanism of HMS as deduced from intermediate partitioning.
The proposed chemical mechanism of HMS is shown. Molecules shown boxed are
detected as products. The origin of the kinetic isotope effects is shown as italicized
notations. Notations, P1 and U refer to the variables of equation 2. The inset depicts two
chromatograms for I216N variant in the absence (solid line) and presence (dashed line) of
the benzylic dideuterium label of HPP.
The mechanism must include displacement of a hydrogen from the benzylic
carbon and as such is expected to show a primary KIE when this atom is replaced with a
deuterium atom. Two of the HMS variants studied do show uncoupling and the formation
of HPA and the measured KIEs for these are modest normal effects around 2.2-2.6. These
values confirm the displacement of the hydrogen in the hydroxylation step but do not
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delineate between hydrogen atom abstraction or hydride transfer mechanisms. The
former of these has been adopted by consensus, fundamentally due to the propensity of
the iron cofactor to carry out one-electron chemistry but either mechanism can account
for the observed product, HMA. The labeled HPP substrate in this case is dideutero at the
benzylic position. As such, the effect is multiplicative with the KIE on the concomitant
formation of the benzylic radical (in the case of H-atom abstraction) or cation (in the
event of hydride transfer). The cation would be predominantly sp2 in character while the
radical could be sp2 or sp3. Although, the extent of these contributions cannot be
established from the data presented, the relatively small KIE observed may argue for a
single contribution altering the rate constant. This would occur with H-atom abstraction
that yields a largely sp3 hybridized benzylic radical. This is the first evidence for the
nature of the hydroxylation mechanism of HMS and indicates that the hydrogen at the
point of substitution is displaced during the hydroxylation step. The effect is considerably
smaller than that measured in other α-KAO enzymes that typically show KIEs for
aliphatic hydroxylation as high as 40 suggesting greater hydrogen transfer optimization
and tunneling in these enzymes (30,39,40,42,43).
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2.4 Discussion
Understanding the role each residue plays in the reaction mechanism is the
common objective of site directed mutagenesis. The purpose of this chapter, however, is
not to assign functions to the residues that were mutated. The principal objective was
instead to determine the kinetic isotope effects for the hydroxylation step and thereby
further define the chemical mechanism of the sister enzymes, HPPD and HMS. The
mutations selected for this study target specific residues implicated to be important in the
mechanisms of HMS and HPPD (13,37,44-46). These form part of a broader effort to
understand the basis of hydroxylation regiospecificity and the enzymatic machinery
required to carryout the NIH shift. Each of the residues mutated is hypothesized to cluster
about the phenol of HPP in both enzymes (Figure 2.1). Two of the residues are distinct in
HPPD (N245, P243) and HMS (I216, T214) and these were mutated to their counterpart
residues (N245I, P243T, I216N and T214P). The conserved serine residue (S230/201)
was shown to form a hydrogen bond with the HMA phenol hydroxyl in the product
complex of HMS (37) and this residue was mutated to an alanine in each enzyme. The
HPPD variant N245Q was included also as it was one of the only variants to yield a large
fraction of the native product, HG.
A number of qualitative mechanistic conclusions based on the ratio of products
are possible. The first is that all enzymes investigated are fully coupled to formation of
products, ie each molecule of dioxygen that is consumed results in the formation of a
product that has, at a minimum, undergone decarboxylation. This is evidence that the
oxidative decarboxylation reaction is tightly coupled to dioxygen reduction. Moreover, it
also to some extent confirms the accepted order of events, in that the hydroxylation
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reaction is contingent on the decarboxylation reaction and thus must occur later in the
catalytic cycle.
The variant forms of HPPD and HMS used in this investigation were selected for
their capacity to form multiple products and most particularly HPA. HPA is an abortive
singly oxygenated and decarboxylated product that is released when a form of either
enzyme fails to hydroxylate the ligand (Figures 2.2 & 2.3). It is thus very likely that HPA
is an intermediate in the catalytic cycle that is common to both enzymes. However,
measurement of the fractional yield of HPA also allows us both to account for the total
products formed and provides a necessary internal reference for a step in the bi- or
trifurcation (depicted as magenta arrows in Figures 2.2 & 2.3) that, in terms of formation
rate constant, is independent of the isotopic substitutions. However, for each instance in
which HPA is made an equal number of oxygen atoms is unaccounted for. These atoms
may result in self-hydroxylation of the enzyme as has been reported for a number of αKAO enzymes (47-49).
For cases that show kinetic isotope effects close to 1, the complexity of the
hydroxylation mechanism of HPPD and the potential for simultaneous compensatory
secondary isotope effects, undermines a direct intuitive explanation. The predicted
mechanistic possibilities depicted in Figure 2.2 are summarized (minus the substrate
binding and product release steps) in Figure 2.4. B to G parts of Figure 2.4 show the
unique linear pathways for the production of HG and QAA and in each case the
competing branch point that forms HPA. Any one path has a unique predicted isotope
effect that reflects only the first intermediate formed during ring oxygenation and this
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outcome is independent of isotope effects in subsequent steps including the
interconversion of the epoxide and cationic species.

Figure 2.4 Summary of the unique linear pathways that yield HG and QAA based on the
mechanism depicted in figure 2.2. Part A shows the predicted kinetic isotope effects
relative to 1 for each of the relevant isotopically sensitive steps in Figure 2.2. Parts B and
C show the two unique pathways for the formation of HG and parts D-G show the four
unique pathways that yield QAA. Gray arrows are included for references only and are
considered as non-operative steps when depicting any one pathway.
If individual linear pathways were exclusively operative for any one product the
interpretation of the kinetic isotope effects would be simple and definitive. That is, an
inverse effect would indicate the intermediacy of the epoxide and an isotope effect of 1
would indicate the benzylic cation intermediate. However, generally we cannot know
which or how many or to what extent any of these possible pathways are biased for any
form of the enzyme nor the value of the intrinsic kinetic isotope effect for any one step.
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Simulation of the interconnected mechanism depicted in Figure 2.2 including all possible
steps shows that the result of multiple pathways occurring and interconverting for any
one product is that the observed net kinetic isotope effect will be ~1 and this is what we
see for most observations (Table 2.3). However, we observe two cases that show
substantially inverse kinetic isotope effects. These are, for the production of HG for the
wild type enzyme and for the production of QAA in the P243T variant enzyme (Table
2.3). These values strongly suggest that for these two cases the epoxide pathway is
dominant (pathways C E and G, Figure 3). This can be concluded for two reasons. Firstly,
these effects are observed for the major fractional product in both instances, negating the
influence of competing pathways for the alternate product, QAA. Secondly, the effects
are significantly inverse and the contribution of other pathways would be to make the
observed value less so. This suggests that for any one pathway the intrinsic oxygenation
isotope effect arises only in this initial pathway selection (between HPA, the epoxide and
the benzylic cation intermediates) and that it is only in the epoxide path that the
possibility for significantly inverse isotope effects is established.
The conclusion is that once the hydroxylation pathway is selected from the three
possibilities branching from the hydroxylating intermediate, the pathway to form either
HG or QAA is linear and as such the isotope effect is defined by only by the relative
probability of one of the first three steps in the absence and presence of the deuteron.
This conclusion is aided by the assumption that no species other than the epoxide and
cationic forms can interconvert. This lack reversibility toward products is consistent
generally as we expect the reduction of dioxygen to be significantly exothermic overall.
However it is also consistent with the mechanism presented in that we would predict high
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forward reactivity for the hydroxylating intermediate, and the relative instability of the
benzylic cation and epoxide species compared to QAA or the dienone intermediate that
precedes rearomatization to HG.
The data obtained suggest that the native HPPD hydroxylation reaction results in
the formation of a ring epoxide as the first intermediate. Inverse KIE values arising from
deuterons placed ortho to the site of hydroxylation are reasonably explicit in this regard.
The observation of a KIE of ~1 in the variant enzymes for the hydroxylation step that
ultimately results in the liberation of HG differs from the wild type observation and
suggests either no change in hybridization at ring C2, in keeping with a benzylic cation or
that we are observing the net effect of multiple simultaneous pathways. Together these
data suggest that the hydroxylation reaction can proceed through either intermediate and
that changes in the active site promote to some extent the benzylic cation pathway for HG
production. KIEs for the formation of QAA can only be measured for three of the variant
enzymes. Again, two show KIEs close to unity and one is significantly inverse, bolstering
the multiple similar pathway theory from above.
The concept of multiple pathways yielding a given product where the overall
reaction traverses an energy landscape involving multiple saddle points has been
suggested for a number of systems (50,51). Such phenomena account for the multiple
conformational states that an enzyme population adopts at any point in time and yet
remains catalytic. It cannot be gleaned if the observations made here are a consequence
of biasing one conformational state and/or a different dynamic population of states in the
variant enzymes. However, it does seem to be a fascinating example of built in
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malleability in the reaction coordinate as a consequence of multiple energetically similar
pathways being available.
The KIEs measured for variants of HMS each show small normal values
consistent with abstraction of the hydrogen during hydroxylation (Figure 2.3). This
narrows the mechanistic possibilities and shows that HMS, in all likelihood, functions
much the same as other aliphatic hydroxylating α-KAO enzymes. The magnitude of the
KIE (~2) suggests that the abstraction of the hydrogen is less optimized than in other
αKAO enzymes and unlikely to be aided by tunneling effects in the hydrogen abstraction
step.
Prior to this investigation, the only available studies to suggest the hydroxylation
reaction intermediate in the NIH shift by HPPD was the work of Gunsior et al., who
observed the liberation of an oxepinone from the P243T variant (46) and Raspail et al.,
who later perpetuated this notion without identifying the actual product formed from an
S246A mutant (equivalent to the S230A mutant in this study) (52). In both studies, the
conclusion was that the oxepinone was a rearrangement product derived from the
abortive release of an epoxide intermediate following the second oxygenation. Our data
show that the P243T and S230A variants make predominantly QAA and not the
oxepinone. The observations of Gunsior et al., who correctly identified the oxepinone, are
accounted for by the conversion of QAA to the oxepinone under the conditions used to
purify the product for identification. Specifically, the use of triflouroacetic acid in the
chromatography buffer, a molecule known to catalyze conversion of quinol derivatives to
oxepinones (53,54). We therefore respectfully propose that the earlier observation was an
artifact. However, the irony of this assertion is that QAA formed by the P243T variant
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clearly suggests the intermediacy of the epoxide in that the KIE for QAA production by
this variant is 0.76 (Table 2.3).
The remaining oddity is that QAA is known to convert quantitatively to HG in
solution at pH 12.0 (55), suggesting that the NIH shift does not require elaborate
enzymatic machinery. QAA however is not a substrate for HPPD as no amount of HG is
observed when QAA is incubated with the enzyme (data not shown). With the delivery of
the second oxygen atom, an accounting of electrons would indicate that the enzyme has
returned to the ferrous state (Figure 2.2). As such the resting enzyme should be in the
correct form to carry out the NIH shift from QAA to yield HG. The tentative conclusion
is that QAA is thus an off-pathway product and not an intermediate that occurs in normal
catalysis.
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Chapter 3

Intermediate Partitioning Kinetic Isotope Effects for the NIH shift of 4Hydroxyphenylpyruvate Dioxygenase and the Hydroxylation Reaction
of Hydroxymandelate Synthase Reveal Mechanistic Complexity
!
!
!

!

!

83!
3.1 Introduction
4-hydroxyphenylpyruvate dioxygenase (HPPD) and hydroxymandelate synthase
(HMS) catalyze similar reactions, using the same substrates, 4-hydroxyphenylpyruvate
(HPP) and dioxygen. Initially both enzymes reduce and activate dioxygen in order to
decarboxylate HPP yielding 4-hydroxyphenylacetate (HPA), CO2 and an activated oxo
intermediate (1). Both enzymes then hydroxylate HPA but do so in different positions.
HPPD catalyzes aromatic hydroxylation at the ring C1 resulting in a migration of the
aceto group of HPA to yield 2,5-dihydroxyphenylacetate (homogentisate, HG), whereas
HMS catalyzes hydroxylation of the HPA benzylic methylene to form Shydroxymandelate (HMA) (Scheme 3.1).
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Scheme 3.1 Reactions catalyzed by HPPD and HMS

Despite modest sequence identity and similarity, the two enzymes clearly have a common
ancestry in that they share numerous active site residues and adopt a highly similar fold
(2). HPPD is in all likelihood the progenitor as it is ostensibly ubiquitous in aerobes
where it catalyzes the second step of tyrosine catabolism while HMS catalyzes the first
step in the biosynthesis of hydroxyphenylglycine, an uncommon tailoring reaction in a
relatively small number of bacteria (3,4).
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Both HPPD and HMS are Fe(II)-dependent dioxygenases, and on the basis of the
reactions they catalyze can be grouped with the α-keto acid dependent oxygenases (αKAOs)(5,6). Structurally HPPD and HMS have no resemblance to other α-KAOs so this
classification is based solely on their chemical reactions (7-9). α-KAOs catalyze an
extraordinary range of chemistries, however, each member begins catalysis with the
cleavage of dioxygen and the oxidative decarboxylation of an alpha-keto acid (almost
universally α-ketoglutarate). These steps are thought to result in the formation of a
common reactive intermediate (Fe(IV)=O) that is then directed to unique purposes by
individual enzymes (10-12). While these purposes include an impressive array of
oxidation reactions, halogenation and even epimerization, this reactive oxo species is
most often used to hydroxylate (6). HPPD and HMS offer respective examples of
aromatic and aliphatic hydroxylation chemistry in which the requisite α-keto acid is
supplied by the pyruvate substituent of HPP rather than from α-ketoglutarate (Figure
3.1).
Aromatic hydroxylation by HPPD induces substituent migration. Guroff et al. in
1960s discovered that aromatic hydroxylation by pterin-dependent hydroxylases can
induce an intramolecular migration or shift of the substituent from the site of
hydroxylation (13). Coined the NIH shift, this phenomenon has since been documented
for a variety of metal-dependent oxygenases (14-17). For essentially all, the shift is
observed with compact substituents such as halides, deuteriums, tritiums, (presumably
protons,) and methyl groups. It has also been observed that, for substituents larger than a
proton, the shift occurs in only a fraction of total catalysis (13,15,18-24). The aromatic
hydroxylation reaction catalyzed by HPPD induces the migration of the comparatively
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large aceto substituent with high efficiency (25) and so, from an experimental standpoint,
is an important example of this chemistry.
Initial attempts to define the mechanism of the HPPD shift used single enantiomer
chiral mono-deutero HPP labeled at the benzylic carbon and subsequent configurational
analysis of the product. It was contended that if a two-electron or carbanion mechanism
was at work, sp3 geometry at the benzylic carbon would predominate in the cleaved
intermediate and therefore a chiral substrate would retain the configuration in the product.
Conversely, if the one-electron mechanism were operative, a symmetrical sp2 in-flight
radical could rotate before recombining with the ring resulting in racemization at a chiral
benzylic carbon. From these experiments Leinberger et al. concluded that the NIH-shift
of HPPD occurred via two-electron mechanism with retention of configuration at the
benzylic methylene C atom (22). More recently, using density functional approaches to
compute the more probable of a comprehensive set of reaction coordinate possibilities,
Borowski et al. concluded that the NIH shift of HPPD was likely to occur via a homolytic
mechanism and that retention of configuration at the benzylic position was simply a
consequence of a low barrier to the transition state (TS) for the displaced group to
recombine with the ring relative to the barrier for bond rotation (26). As such, there is
some incongruity in the literature that is open to be settled by experimental observation
that reports discriminating evidence for the mechanism of the NIH-shift in HPPD.
The hydroxylation reaction catalyzed by HMS is less complex than that of HPPD
and is thought to involve only an initial hydrogen abstraction by the Fe(IV)=O species
from the benzylic position to form a benzylic radical followed by hydroxyl addition from
the resulting Fe(III)-OH species (25). Computational methods have provided a
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comprehensive description of the basis for hydroxylation regiospecificity in HMS and
have suggested that H-atom abstraction forming a benzylic radical followed by oxygen
rebound is the dominant mechanism (27,28). Experimental evidence for the mechanism
has come from kinetic isotope effect (KIE) values for the hydroxylation reaction from
intermediate partitioning (vide infra) and were consistent with H-atom abstraction as the
first step (12,25,29).
The fundamental objectives of this study were to obtain experimental evidence
that discriminates between the heterolytic and homolytic NIH-shift mechanisms with
HPPD and to define the geometry of the benzylic radical that forms with H-atom
abstraction in HMS (highlighted steps in Figure 3.1). The measurement of KIEs for the
relevant catalytic steps would provide data evidence for the mechanism(s), but for both
HPPD and HMS this observation cannot be made directly as the hydroxylation and NIH
shift steps are kinetically shrouded in single turnover reactions (30-32).

We have

recently shown that HPPD wild-type and also HPPD and HMS variants exhibit
bifurcations that produce multiple products (25). For HPPD, bifurcation at the NIH-shift
step yields either quinolacetic acid (QAA), a molecule that is hydroxylated but has not
undergone the shift, or the native shift product, HG (25,33), whereas bifurcation for Hatom abstraction step that forms HMA yields HPA, an intermediate that has undergone
decarboxylation but is not hydroxylated (25) (Scheme 3.2). Thus these systems are
amenable to the measurement of intermediate partitioning based KIE values. The basis
for this method is that the ratio of products is a direct result of a probability-based
selection that is defined by the decay rate constant for individual paths bifurcating from
some reactive state of the enzyme (34). As such, substitutions of heavy isotopes for atoms
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that are involved in the chemistry of these diverging steps can alter the balance of the rate
constants and thus the product ratio.

OH

O
O

O
Fe(II)

O2

4-hydroxyphenylpyruvate (HPP)

CO 2
OH

HO

O

O

O
O

O

O
Fe(IV)

Fe(II)

HO

O

O

Fe(III)

hydroxylation

dissociation

P2
O

O

OH
O

Fe(II)

Fe(II)

HO

hy
ab dro
str ge
ac n
tio
n

sh
H

NI
H O

tautomerization

OH

hydroxymandelate
bifurcation

O

O

k3

n

OH

O

homogentisate
bifurcation
O

tio

HO

ia

k2

k3

oc
ss

ift

di

er
om
ut n
ta atio
iz

k2

4-hydroxyphenyl
acetate (HPA)

OH

P2

OH
O

O

O
O
HO

Fe(II)

O

HO
O

O
Fe(II)

dissociation

quinolacetate (QAA)

dissociation

P1

HO

OH

P1

OH
O

O

O

HO

homogentisate (HG)

O

S-hydroxymandelate
(HMA)

Scheme 3.2 Proposed Bifurcations at the NIH-shift in HPPD and H-atom abstraction
steps in HMS

!

!

89!
Thus an intrinsic kinetic isotope effect for a specific reaction step can be calculated
simply. This accurate and highly robust method was originally applied to the P450
hydroxylases and more recently to mono- and dinuclear Fe(II) dependent oxygenases
(16,35-37). The data we have obtained via these methods give KIE values that are
consistent with the mechanisms proposed for each of the catalytic steps, at least narrow
the mechanistic possibilities and suggest that alternate pathways can be induced that yield
the same product in variant forms of the enzymes.
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3.2 Materials and Methods
Materials. HPP and HG were purchased from Acros Chemicals. HMA and 4hydroxyphenylacetate (HPA) were obtained from Sigma-Aldrich. Phusion® HighFiedility PCR Master Mix and Competent BL21(DE3) Escherichia coli cells were
obtained from New England Biolabs. IPTG was from Gold Biochemicals. D2O and
CDCl3 were obtained from Cambridge Isotope Laboratories. DMSO-d6 was from Acros
Chemicals. The gene for mouse phenylpyruvate tautomerase (PPT) optimized for
expression in Escherichia coli and including codons for a His-Tag was purchased from
EnzymaX and subcloned into the Nde I and Xho I restriction sites of pET17b for
expression. Q-Sepharose was from Bio-Rad. Sephacryl S-200 was obtained from
Amersham. Quinolacetate (QAA) was made using the HPPD P243T variant and purified
as previously described (33). 3’,3’-Diduetero-HPP was prepared according to our
previously published method (32). Solutions of the enol form of HPP were prepared by
dissolving crystalline enol-HPP (as purchased) in the aprotic water miscible solvent,
methanol to prevent ketonization. Chiral shift reagent, rhombamine macrocycle, was a
kind gift from Dr. Koichi Tanaka (38). All other chemicals, buffers, and biological media
were obtained from Fisher Scientific or Sigma-Aldrich Chemicals and were of high
purity.

Mutagenesis. pET17b-derived (Novagen) plasmids carrying the Streptomyces avermitilis
HPPD gene (pSAHPPD;(39)) and the Amycolatopsis orientalis HMS gene (pAOHMS;
(2)) were mutated as previously described to obtain the N245Q, P243T, S230A, N245S
variants of HPPD and the S201A variant of HMS (25,33). An additional HPPD variant
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for this study, F364I, was obtained using the Stratagene QuickChange protocol using
Phusion® High-Fidelity PCR Master mix and the following oligonucleotide:
TCGGCAAGGGCAACATCAAGGCCCTGTTC, paired with an oligonucleotide that
was its reverse complement. All variants were screened for spurious mutations by
sequencing the entire dioxygenase genes (Sequetech, Mountain View CA).

Expression and Purification. The apo-forms of wild-type and variants of HPPD and
HMS were expressed and purified using ammonium sulfate fractionation, anion exchange
chromatography and size exclusion chromatography according to published methods
(2,39).
His-tagged PPT was purified using the following protocol. Aliquots from frozen
cell stocks were plated (200 µL/L of culture) on LB agar, 100 µg/mL ampicillin. After
incubation for 9–12 h at 37 °C, the cells from two plates were suspended in ~20 mL of
LB broth and used to inoculate 1 L of LB broth with 100 µg/mL ampicillin. The culture
was grown with vigorous shaking (225 rpm) at 37 °C until the cell density had reached
on OD600 of 1.0. At this time, IPTG was added to a final concentration of 0.1 mM and
incubation was continued for 2.5 h. The cells were harvested by centrifugation at 4665 g
for 30 min and used immediately for protein purification. Unless otherwise stated, all
subsequent purification procedures were undertaken at 4 °C. Cells were resuspended
using 20 mL of 20 mM HEPES, pH 7.0, per L of culture and lysed with sonication (2 x 6
min at 45 W) using a Branson sonicator fitted with a blunt tungsten tip. The temperature
of the solution was monitored to ensure that it did not exceed 10 °C. The lysed cells were
then centrifuged at 15600 g for 30 min, and the pellet was discarded. Streptomycin
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sulfate in water was then added to the supernatant to a final concentration of 1.5% w/v.
The mixture was stirred for 10 min and centrifuged at 12,900 g for 15 min. The
supernatant was then loaded directly onto a Talon® metal affinity column pre-equilibrated
in the 20 mM HEPES, pH 7.0 at a flow rate of 1 mL/min. The column was washed with
20 mM HEPES, 10 mM imidazole, pH 7.0 to elute nonspecifically bound proteins. The
PPT was eluted with a linear 600 mL gradient from 10 to 250 mM imidazole in 20 mM
HEPES, pH 7.0 at a flow rate of 1 mL/min. The fractions containing PPT were pooled
and stored at –80 °C.

KIE Values from HPLC Product Analysis. The ratio of products for wild-type and each
variant enzyme were determined using high-pressure liquid chromatography. Enzyme
turnover reactions were undertaken at 25 °C and were comprised of 25-30 µM ferrous
sulfate, 10-20 µM enzyme (wild-type or variant HPPD or HMS), 1 mM reductant (either
βME or ascorbic acid), 250 µM O2, and 100-250 µM HPP (either 3’,3’-dideutero or
diprotio) in 10 mM potassium phosphate, pH 7.0. Isotope effects were based on peak
areas for products measured by HPLC as previously published (25).
KIE values measured with R-3’-monodeutero HPP were obtained from coupled
turnover reactions in which the stereospecifically labeled monodeutero substrate was
formed and consumed in situ. R-3’-monodeutero HPP was prepared using
phenylpyruvate tautomerase (PPT) in deuterium oxide solvent. PPT catalyzes a
stereospecific reaction where it interconverts the enol and keto forms of HPP by
incorporating or abstracting a proton at the pro-R position (40). The ratio of products
observed for HPPD or HMS when R-3’-monodeutero HPP was used as a substrate was
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determined by adding the enol form of HPP to a reaction that had both PPT and HMS or
HPPD activities. The reaction was designed such that the combined PPT and nonenzymatic conversion of enol-HPP to R-3’monodeutero-keto-HPP was 7-fold faster than
the non-enzymatic conversion of the enol-HPP to the S-3’monodeutero-keto-HPP and the
HMS or HPPD activity was 4-fold greater than that of PPT, accounting for both the
solvent kinetic isotope effect (SKIE) on the product release step of HPPD and HMS and
the SKIE for PPT (30,32,40,41). Enzyme turnover reactions were undertaken at 25 °C
and were comprised of ferrous sulfate equivalent to the concentration of HMS or HPPD
that gave 1.06 U activity (12.5 µM S201A HMS or 106 µM F364I HPPD), 0.28 U of PPT,
1 mM ascorbate in 5 mM sodium phosphate buffer prepared in deuterium oxide, pD 7.0
(U is a unit of enzyme activity and is equal to 1 µMole of substrate consumed or product
evolved per min). The low concentration of buffer used in these reactions suppresses the
observed rate-constant for the non-enzymatic conversion of the enolic HPP to ketoic HPP.
The reaction was initiated by the addition of 50 µM enol HPP in 100% methanol. After
completion of the reaction all other steps required to determine the product
concentrations were as previously published (25).

Calculation of KIEs. Kinetic isotope effects were calculated using equation 1 that
computes the factor of perturbation of the product ratio in the presence of the deuterated
substrate for the case of a bifurcating mechanism and incorporates a correction
accounting for the fractional extent by which Dkobs is reduced from the intrinsic value
(Dk2) by the bifurcation (34).
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E + P1

Intermediate
k3

E + P2

equation 1. Dkobs= (P1/(P1+P2))H = Dk2 + (k2/k3)
(P1/(P1+P2))D 1 +(k2/k3)
In this equation, Dkobs is determined by measuring P1, the concentration of product for
which the isotope effect is being determined (HG or HMA for HPPD and HMA for
HMS) and P2, the concentration of the product that results from bifurcation in a step that
is insensitive to the isotopic insertion (QAA or HPA for HPPD and HPA for HMS). In
each measurement the total consumption of molecular oxygen was compared to the total
concentration of products formed, to ensure that all catalysis was considered.

Preparation of Monodeuterated HG from Wild-type HPPD. For the production of HG in
sufficient quantity for NMR analysis a large-scale turnover reaction (40 mL) was
undertaken in D2O with wild-type HPPD. Reaction mixture was comprised of 420 U of
wild-type HPPD, 112 U of PPT, 60 µM ferrous sulfate and 1 mM ascorbate in 5 mM
sodium phosphate buffer, pD 7.0 and was initiated with the addition of 1.5 mM enol HPP
in methanol. The reaction was run at 25°C and was equilibrated with 100% O2 by stirring
in a vessel with two small ports so that 100% dioxygen gas could continuously flush the
headspace of the container. Complete conversion of the available HPP to HG was
achieved within ~40 minutes, as determined by analytical reverse phase HPLC using
published methods (25). The reaction was then brought down to pD 2.0 by the addition of
H2SO4 to stabilize the HG hydroquinone and the precipitated protein was removed by
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centrifugation at 12,900 g for 20 min. Supernatant was then passed through 10 kDa
nominal molecular weight limit centrifugal filter (Vivaspin15) by centrifuging at 3,000 g
to remove residual soluble peptide. The filtrate was then lyophilized overnight to a
volume of ~5 mL and the sample was loaded on to Sep-Pak® Vac 35 cc C18 column preequilibrated with 40 mM sodium phosphate buffer, pH 7.0. The column was washed with
60 mL of H2O and the HG was then eluted with 10% acetonitrile in water. Each eluted
fraction was examined spectrophotometrically for the characteristic λmax absorbance of
HG at 290nm. Fractions showing significant absorbance at 290nm were combined
together and lyophilized to obtain dry (powdered) HG.

Chiral Shift Analysis of Monodeuterated HG. Lyophilized HG was dissolved in CDCl3
containing 10% DMSO-d6, out of which 5 mg of HG was taken for NMR analysis. As a
standard, a comparable amount of unlabeled HG solution in CDCl3 containing 10%
DMSO-d6 was also prepared. Monodeuterated HG and unlabeled HG solutions were
titrated with 0 to 0.05 eq rhombamine macrocycle (chiral shift reagent) by small additions
(38). 1H NMR spectra were recorded on a 500 MHz Bruker NMR instrument.
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3.3 Results
Product Analysis and Characterization of Variant Enzymes. All the HPPD and HMS
variants except F364I HPPD and N245D HPPD have been characterized in prior work
(25). The product ratios for wild-type, N245Q, N245S, P243T and S230A vary slightly
from those previously published. However, the KIE values obtained by partitioning
methods are calculated from a ratio of ratios and so are largely immune from such
variation (equation 1). F364I HPPD and N245D HPPD could be expressed and purified
using the same methods as wild-type HPPD (39). Interestingly F364I HPPD showed four
different products from product analysis (Table 3.4). Of which the most interesting was
HMA, the product of the HMS reaction. This was consistent with the work of O’Hare et
al. and Gunsior et al. who also observed HMA production with this variant (42,43).
While rationalizing the function of individual residues is secondary to the purpose of this
study, it is interesting to note that the position occupied by F364 in the structure of HPPD
is filled by I335 in the structure of HMS (44). As such this mutation yields one of the
only single positional-switching variants for these two enzymes that has resulted in the
alternate activity to any significant extent. N245D was a largely competent HPPD,
successfully completing NIH shift to form HG in 50% of total turnovers with the
remaining fractions of turnover yielding QAA (20%) and HPA (30%).
Table 3.1 Product Ratios from which KIE Values for the Formation of HG were Derived
Product%
WT HPPD
N245Q
N245D
N245S
P243T
S230A

HG%
3’3’H
90.37
51.83
51.91
3.36
8.4
6.7

3’3’D
95.6
58.72
58.57
2.45
7.39
6.75

QAA%
3’3’H
0.98
3.00
21.24
90.10
45.05
36.48

3’3’H – diprotio HPP, 3’3’D – dideutero HPP

!

!

3’3’D
0.66
2.98
26.80
91.45
43.45
40.15

HPA%
3’3’H
8.65
45.08
26.86
6.60
46.50
56.82

3’3’D
3.75
38.10
14.64
5.40
49.15
53.20
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KIEs for the NIH-shift from Intermediate Partitioning in Wild-type and Variant
HPPDs. Despite that HPPD catalysis represents one of the more compelling examples of
shift chemistry, the NIH shift step neither contributes to the limiting rate of turnover nor
is it resolved kinetically in single turnover reactions and so is difficult to study by
conventional methods (30,31). Intermediate partitioning is one of the few experimental
methods capable of providing direct evidence for the chemistry occurring in this step.
Moreover, the precision obtained with this method is sufficient to discern between
mechanisms based on KIEs of small magnitude as are often obtained for secondary
deuterium isotope effects arising from subtle hybridization changes at specific carbon
atoms. Table 3.2 shows the utility of the product partitioning in differentiating between
possible pathways for the NIH shift. For HPPD, QAA acts as an internal reference
product for the shift step, having undergone hydroxylation but not the shift and thus its
formation rate constant would not be sensitive to deuterons placed at the benzylic carbon
(C3’). To form HG, however, the enzyme must transiently severe the bond to this carbon
and so the rate constant for the formation of HG will reflect an extent of influence of
benzylic deuterons (Scheme 3.2). Wild-type HPPD and variant N245Q show KIE of 1 for
the formation of the native product HG, which indicates that no significant geometric
change at C3’ occurs in the formation of the (first) TS for the shift, or more precisely that
sp3 geometry predominates. The interpretation of this number does not converge on single
mechanism. A trigonal C3’ in the shift TS is consistent with and early TS that has
retained much of the initial hybridization of the pre-shift benzylic methylene. It does not
however, indicate explicitly that the mechanism is hetero- or homolytic, as the TS could
readily progress to either an in-flight radical or carbanion intermediate.
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Table 3.2 The NIH Shift KIEs from Wild-type HPPD and Variantsa
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Variant
HG%
QAA%
HPA%

Wild-type
90
1
9

N245Q
52
3
45

O

early TS

N245D
52
21.2
26.8

N245S
3.4
90
6.6

P243T
8.4
45
46.5

S230A
7
36
57

D

kobs HG
0.990±0.001 0.99±0.03 1.03±0.01 1.39±0.02 1.08±0.05 1.08±0.01
Replicates
2
2
2
2
2
2
a

N.B. All product percentages are those obtained with the protio substrates.

In contrast, N245S HPPD showed distinctly normal KIE of 1.39. This indicates
that the (net) rate constant leading the formation of HG for this variant is slowed by
deuterons in the benzylic position and that a transient geometry change at C3’ must
accompany the formation of the shift TS. An sp3 to sp2 hybridization change resulting
from homolytic severing of the C1-C3’ bond would account for the observed effect with
this variant suggesting a later TS in which the unrestrained in-flight radical character
(sp2) is developed in the TS.
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Taken together, and assuming that the reaction traverses the same barrier for both
wild-type and variants, these data support homolytic cleavage of the bond to the
methylene attending the NIH-shift. This conclusion is consistent with what has been
proposed by Borowski et al. who, from calculation, also propose a highly unstable
biradical intermediate resulting from the severed bond that collapses to form the new
bond to the ring (26). All other HPPD variants tested in this manner, N245D, P243T and
S230A, show small secondary normal KIEs (1.03-1.08) for the formation of HG. Within
error, these values suggest shift TS geometry similar to the wild-type (C3’ -sp3).

NMR Chiral Shift Analysis of 3’-Monodeutero-HG. To further add to our evidence for
the nature of the NIH shift chemistry we examined the native product, HG, for evidence
of deuterium scrambling when derived from stereospecifically labeled HPP (R-3’monodeutero). This experiment was undertaken to simply to reaffirm the observations of
Leinberger et al. who conceded that derivatization of the product may have influenced the
degree of scrambling observed (22). The hypothesis for this experiment is that heterolytic
cleavage of the C1-C3’ bond would dis-favor racemization of the label at C3’ due to the
polar trigonal shape of the in-flight carbanion, while the inherently planar and
symmetrical sp2 radical in this position could permit scrambling. Figure 3.2 shows NMR
spectra that depict a titration of HPPD-derived monodeuterated HG with rhombamine
macrocycle chiral shift reagent (38). In this figure, inset spectra in blue are for unlabeled
HG. The lower of these standard spectra is without shift reagent and shows a single shift
for the equivalent benzylic protons. The upper standard spectrum shows splitting of these
two benzylic protons in AB spin system with the addition of the shift reagent.
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Figure 3.2 Evidence for a single enantiomer of homogentisate derived from R-3’-deutero
4-Hydroxyphenylpyruvate. A. 5 mg of HG derived from HPPD reacting with R-3’monodeutero-HPP was dissolved in CDCl3, 10% DMSO-d6. A comparable amount of
unlabeled HG solution in CDCl3 containing 10% DMSO-d6 was also prepared.
Monodeuterated HG and unlabeled HG solutions were titrated with 0 to 0.05 eq
rhombamine macrocycle (chiral shift reagent) by small additions. 1H NMR spectra were
recorded on a 500 MHz Bruker NMR instrument. Blue spectra show the spectra of 3’diprotic HG in the presence and absence of the chiral shift reagent. B. rhombamine
macrocycle (chiral shift reagent)
!
!
!!!!!!!!!!!!!The spectra in black include the titration of the HPPD-derived HG with the shift
reagent. In the absence of the shift reagent two HG populations are observed, one
resonates at 3.34 ppm and corresponds to the benzylic protons of unlabeled HG. The
second resonance at 3.32 ppm is for R- or S- and/or RS 3’-monodeutero HG. The greatest
extent of splitting for unlabeled HG was observed for 0.035 equivalents of the shift
reagent, however HPPD derived monodeutero-HG does not show evidence of splitting
indicating a single enantiomer of monoduterated HG. It can now be stated that this lack
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of label scrambling is indeed characteristic to the reaction. However, as noted by
Borowski et al. this evidence by itself is not discriminating for the chemistry of the shift.
Such a result would be predicted for the heterolytic pathway but also equally consistent
with a homolytic pathway in which the collapse of a biradical intermediate occurs orders
of magnitude more rapidly than the time taken for C2’-C3’ bond rotation (26).
Table 3.3 Product Ratios from which KIE Values for the Formation of HMA were
Derived
Product% !
F364I HPPD!
S201A HMS!

HMA%
3’3’H!

3’3’D

3’-R-D

HPA%
3’3’H!

3’3’D

3’-R-D

20.48
97

5.82
47.93

10.70
91.27

15.00
3.00

13.84
52.07

14.40
8.73

3’3’H – diprotio HPP, 3’3’D – dideutero HPP, 3’-R-D – R-monodeutero HPP

Deconstruction of Net KIE values for the Production of HMA Using Stereospecifically
Deuterated HPP. In prior work, we have measured the primary deuterium KIE on the
initial hydrogen abstraction step of the hydroxylation reaction for HMS using 3’,3’dideutero-HPP (25). While the value measured was modest (2.2-2.6 dependent on the
enzyme variant) it includes a multiplicative component from the geometry at the benzylic
carbon for the deuteron not in-flight (Table 3.4). Two variants were selected to measure
KIEs for the production of HMA with R-3’-monodeutero-HPP. The first was S201A
HMS and the second was F364I HPPD (that makes 20% HMA). Table 3.4 includes the
percentage of each product produced by these variants and KIEs measured for the
formation of HMA with 3’,3’-dideutero-HPP as well as 3’-R-monodeuterated HPP. With
3’,3’-dideutero HPP as a substrate, S201A HMS and F364I HPPD show combined
primary/secondary KIEs of 2.02 and 3.52 respectively. For KIEs measured with 3’-R-
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Table 3.4 Delineation of KIE for the Formation of HMA to Identify Hybridization
Geometry of the Radicala
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ef
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O

Fe(IV)
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P2

D
O

O

H
O

D
HO

O
O

Fe(III)

Fe(III)

sp2

Variant
HG (%)
QAA (%)
HPA (%)
HMA (%)
Total (%)

F364I HPPD
47
19
15
20
100

S201A HMS
0
0
3
97
100

D

kobs, 3’,3’-dideutero HPP
Replicates

3.52 ± 0.1
2

2.020 ± 0.004
3

D

1.92 ± 0.16
2

1.06 ± 0.04
3

kobs R-3’-monodeutero HPP
Replicates
a

sp2

N.B. All product percentages are those obtained with the protio substrates.

monodeuterated HPP as a substrate, S201A HMS showed a value of 1.06 ± 0.04 for the
production of HMA indicating the benzylic carbon retains predominant sp3 character in
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the TS for the initial hydrogen abstraction. Conversely for F364I HPPD, the secondary
KIE measured with 3’-R-monodeuterated HPP for the formation of HMA was 1.92 ±
0.16 indicating that a geometry change accompanies benzylic hydrogen abstraction for
this HPPD variant. This would be consistent with a change from sp3 to sp2 geometry in
the TS for this step.

3.4 Discussion
Both HPPD and HMS have been studied in single turnover reactions in some
detail (30-32). While both enzymes accumulate multiple transients, none of the steps
observed show sensitivity to isotopic substitutions at positions of the substrate that are
involved in hydroxylation (30). As such it was concluded that the hydroxylation steps of
the catalytic cycle were fast relative to other steps and so the reactive species involved
could not be observed directly by kinetic methods. Recently we have shown that active
site variants of both enzymes can form alternate products in some fraction of total
turnover (25,33). While it may be tempting to rationalize the meaning of the ratios of
products observed with regard to the function of specific residues, the ratios are
dependent on the prevailing conditions of the reaction (data not shown) and so offer
limited opportunities for meaningful conclusions. However, multiple products indicate
that bifurcations (and trifurcations) are occurring at identifiable stages of catalysis.
Specific heavy isotope substitutions have therefore the potential to alter the rate constant
associated with one arm of the bifurcation and as such the KIE for that step can be
calculated if the other arm(s) of the branch is unaffected by the substitution (equation 1,
Scheme 3.2). While the data obtained by such methods can be exceedingly precise, they
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are also easily over-intrepreted. The inherent kinetic complexity of a multiproduct system
dictates that rationalization of results will likely offer explanations that are narrow
relative to all possible mechanistic and kinetic possibilities. Herein, we have attempted to
explain our data primarily on the basis of geometric changes in the transition state of the
step affected by the isotope substitution. This approach assumes that the individual steps
are largely irreversible or that they are commitment forward is such that any reversibility
can be ignored. This is broadly reasonable as oxygenases catalyze highly exothermic
reactions for which most steps will be irreversible and/or committed forward.
Reversibility is only relevant for those steps that define the ratio of products of interest.
That is, the initial steps that lead from the branch point to the products that define the KIE
value. Reversibility in either of the steps leading away from bifurcating intermediate will
increase the proportion of the other product independent of the TS geometry. Thus it
should be noted that the assumptions on which conclusions are based in this study cannot,
in the absence of additional data, be validated and so what follows is a confined set of
conclusions that attempt to form a reasoned explanation for the observations but cannot
account exhaustively for the nuanced nature of the interpretation of individual KIE values
for complex systems.
In our earlier work using similar methods we measured KIE values on the ringoxygen insertion step for HPPD using ring-per-deutero HPP and on the hydrogen
abstraction step of HMS using 3’,3’-dideutero HPP. We observed an inverse secondary
isotope effect for ring hydroxylation in HPPD consistent with the formation of an
epoxide as the initial product of oxygen addition to the aromatic ring. For HMS,
abstraction of the S-deuteron from HPP dideuterated at the benzylic position gave a
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normal primary effect consistent with H-atom abstraction before hydroxylation (25)
(Figure 3.1). In the present study we have again investigated one branch-point for each
enzyme (Scheme 3.2). For HPPD we have studied a branch point beyond ring-oxygen
insertion from which either the native product HG or QAA is formed. This branch was
probed using 3’,3’-dideutero HPP to examine if the formation rate constant for HG is
influenced by geometric changes at the benzylic carbon during the NIH shift. The shift
reaction was further studied using R-3’-monodeutero HPP to detect evidence of
racemization at the benzylic carbon during the aceto group migration. For HMS we have
expanded our prior investigation of the hydroxylation step with the use of R-3’monodeutero HPP. The single enantiomer of the substrate permitted the measurement of
the contribution from the non-abstracted deuteron to the KIE value measured for HMS
variants in prior work and so has provided evidence for the hybridization state at the
benzylic carbon atom in the TS for the step that precedes hydroxylation.
The hydroxylation/shift reaction of HPPD has long been a biochemical curiosity
and has been investigated using experimental and computational methods. The earliest
direct evidence for the chemistry of the shift in HPPD came from Leinberger, et al. who
were able to show that the configuration of the benzylic carbon was retained during the
shift and proposed that a two-electron process (heterolytic pathway) was at work (22).
The conclusions made here differ from those of Leinberger. Our KIE data show that no
isotope effect is observed for the formation of HG when 3’,3’-dideutero HPP is used as a
substrate (Table 3.2). While this alone could be said to be consistent with a TS leading to
a benzylic carbanion (sp3) intermediate it is also consistent with an sp3 hybridized TS that
exhibits little of the character of an ensuing sp2 hybridized intermediate (i.e. an early TS).
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The more definitive observation is the KIE value measured for this branch with the
N245S variant, which is distinctly normal (1.4). If we accept that the mechanism is
conserved between the wild-type and variant, this value represents a more mature TS in
which the benzylic methylene is largely departed from the ring C1 and has adopted the
geometry of an untethered radical (sp2) (Scheme in Table 3.2).
Leinberger, et al. showed both that configuration at the benzylic position was
retained and that the product HG was not racemized to any measurable extent (22). This
important work established a fundamental facet of HPPD chemistry. However, the
methods chosen required derivatization of HG in order to compare chirality with
synthesized chirality standards, undermining to some extent the certainty of the
observation. In order to solidify the conclusions regarding racemization during the NIHshift, we repeated the scrambling experiments of Leinberger et al. using a chiral shift
reagent to induce chirality, a method that has the advantage of not chemically altering the
product. Our data confirm the earlier observations that the monodeuterated HG formed in
the reaction of HPPD with R-3’-monodeutero HPP is a single enantiomer and so
conclude simply that bond rotation does not occur during the migration step (Figure 3.2).
Borowski et al. have proposed that the NIH shift occurs through a homolytic pathway
that does not induce racemization due to a relative high barrier for bond rotation
compared to that for radical collapse that forms the new substituent bond (26). The
integrated conclusion is thus in agreement with that of Borowski and suggest homolytic
cleavage in the first shift TS followed by facile collapse of a biradical intermediate.
Partitioning KIEs measured with deuteriums substituted at the benzylic carbon of
HPP for S201A HMS and F364I HPPD for the product HMA report the geometry of the
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H-atom abstraction TS. Our data indicate that these variants undergo different geometry
changes at the benzylic carbon during the initial H-atom abstraction. KIE values
measured using 3’,3’-dideutero HPP are multiplicative for the hydrogen abstracted and
the hydrogen retained and thus are expected to be greater than KIE values measured with
R-3’-monodeuterated HPP (given that inverse effects are not predicted). Wojcik et al. and
Neidig et al. both concluded from density functional approaches that the HMS
hydroxylation chemistry involves H-atom abstraction leading to formation of a largely
planar (predominately sp2) benzylic radical (27,28). Our conclusions regarding this step
deviate only slightly from these prior determinations. The measured KIEs for HMA
formation with both HPPD (F364I) and HMS (S201A) are internally consistent in that
each value determined with the monodeuterated substrate is smaller than the value
recorded with the 3’,3’-dideutero substrate. For S201A HMS, KIE values with 3’,3’dideutero HPP are higher than with R-3’-monodeutero HPP by a factor of two indicating
a primary KIE for abstraction, suggesting a more optimized benzylic hydroxylation
process in HMS compared to the HPPD F364I variant. However, the KIE obtained with
R-3’-monodeutero HPP is, within error, unity indicating that the benzylic carbon does not
change geometry significantly to reach the hydrogen abstraction TS. The conclusion in
this case is that the TS for this step has sp3 character at C3’. Interestingly, Wojcik et al.
proposed that the S201 residue is vital for hydroxylation regiospecificity by tethering the
phenol of HPA at unique angles in HPPD and HMS and so mutation of this residue may
have resulted in a change in geometry in the abstraction TS (27). For F364I HPPD the
KIE values for H-atom abstraction TS are, 1.83 for hydrogen abstraction and 1.92 for
geometry changes at the benzylic carbon in this step, suggesting that the benzylic carbon
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develops predominant sp2 character with relatively little lengthening of the bond to the
abstracted hydrogen in the TS. These values are inline with the prior modeling studies
and raises the possibility for redundancy in the chemistry, where the dominant chemistry
is to form a TS that is largely sp2 hybridized at C3’ but a HMS variant can be made to
exhibit sp3 character at this position for the TS of this step and yet yield the same product.
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Chapter 4
Characterization of Active Site Variants of 4-Hydroxyphenylpyruvate
Dioxygenase from Streptomyces avermitilis
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4.1 Introduction
4-Hydroxyphenylpyruvate dioxygenase (HPPD) is a non-heme Fe(II)-dependent
oxygenase that catalyzes the second step of the tyrosine catabolism pathway, the
conversion of 4-hydroxyphenylpyruvate to homogentisate (Scheme 4.1) (1). Based on the
reaction catalyzed, HPPD is an α-keto acid dependent oxygenase (2,3). However, HPPD
is an exception in this class of enzymes as it does not use α-ketoglutarate as the source of
electrons for the reduction of dioxygen. HPPD has a requirement for just two substrates,
4-hydroxyphenylpyruvate (HPP) and molecular oxygen (4,5). Collectively, HPPD
catalyzes decarboxylation, aromatic hydroxylation and substituent migration in a one
catalytic cycle to form homogentisate. The reaction involves two separate half-reactions,
a decarboxylation half reaction and a hydroxylation half-reaction.

OH

OH

HPPD
O2
O

O
O

CO 2

O

OH

O

4-hydroxyphenylpyruvate

homogentisate

Scheme 4.1 Reaction catalyzed by HPPD

The majority of the α-keto acid dependent oxygenases incorporate one atom of
dioxygen at the α-keto carbon displacing the carboxylic acid as carbon dioxide and then
incorporate the second oxygen atom as a hydroxyl. There are a number of plausible
chemical mechanisms available in literature for this chemistry (6-9), however, for the
majority of the three-substrate α-keto acid dependent oxygenases, there is no direct
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evidence of the accumulation of catalytic intermediates. As such much of what is
proposed for mechanism in this family of enzymes is derived from chemical intuition,
computer modeling and consensus rather than experimental evidence. One clear
exception is the work of Bollinger et al. who have identified a ferryl species that
accumulates prior to hydroxylation in the enzymes taurine:α-ketoglutarate dioxygenase
(TauD), prolyl-4-hydroxylase, and the halogenase CytC3 (7,10,11). The two-substrate
enzymes, such as HPPD, have entirely different kinetics and evidence for the
accumulation of multiple intermediates was first offered in 2005 when Johnson-Winters
et al. obtained data for the accumulation of three intermediates in a single catalytic cycle
of HPPD (Scheme 4.2) using spectrophotometric pre-steady-state methods (Figure 4.1)
(5,12).

k1

HPPD•Fe(II)•HPP + O2

I

k2

II

k3

III

k4

HPPD•Fe(II)•HPP + HG

Scheme 4.2 The kinetic model for a single catalytic cycle of HPPD (12)
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Figure 4.1 Single-turnover kinetics for Wild-type HPPD. (A) Stopped-flow traces and
their fits (---) at two different wavelengths, 380 nm (blue) and 490 nm (red) (B)
Concentration profiles of species observed in a single-turnover reaction, where
intermediate I is depicted in green, intermediate II in violet, intermediate III in orange
and HPPD•Fe(II)•HPP + HG in black. (Enzyme-substrate complex was excluded from
this figure because of its higher concentration.) (C) Deconvoluted intermediate spectra
from the fit to the model depicted in Scheme 4.2. HPPD•Fe(II)•HPP (blue), intermediate
I (green), intermediate II (violet), intermediate III (orange), and HPPD•Fe(II)•HPP + HG
+ CO2 (black). This figure has been taken from (12).
Figure 4.1 B depicts a concentration profile of all accumulating species in a
single turnover of HPPD from Streptomyces avermitilis. The kinetics indicate relative
high fractional accumulation of each species, the first intermediate accumulating to 40%
of total species at 14 ms, the second intermediate accumulating to ∼50% at 47 ms and the
third intermediate to 70% at 220 ms. (12).
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Scheme 4.3 Catalytic cycle of HPPD. Intermediates discussed in this study are depicted
with their identity.

Of the three transient species observed, intermediate III has been identified as
the HPPD•Fe(II)•HG product complex. This identification was made from a combination
of rapid chemical quench and rapid-mixing fluorescence spectroscopy (12). The identity
of the other two intermediates could not be established directly, however, select
observations permitted some speculative assignments for these intermediates. The
formation rate constant of the first intermediate exhibited a first-order dependence on the
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concentration of dioxygen. This dependence permitted the calculation of a second-order
rate constant for the addition of dioxygen to the HPPD•Fe(II)•HPP complex (105 M-1 s-1),
a value several thousand fold faster than the rate of reaction of the holoenzyme alone
with dioxygen. In addition, decay of the first intermediate was not influenced by the
deuterons placed on an aromatic ring of HPP, suggesting that intermediate I occurs prior
to ring hydroxylation. Consistent with this conclusion, though not definitive in terms of
timing, was that this species did not have absorption transitions in the far-visible to nearIR region which are thought to be characteristic of the Fe(IV)-oxo intermediate (Scheme
4.3) (3).
Data pertaining to the second intermediate suggest that it arrives after the ring
oxygenation reaction but before the formation of HG. A small normal kinetic isotope
effect was observed for the decay of the second intermediate (k3) in the presence of ringdeuterated substrate, indicating that this process is part of the aromatic oxygenation
chemistry. Interestingly, the decay of intermediate II occurred concomitantly with an
increase in the fluorescence that was correlated with the appearance of the product, HG.
This prompted the proposal that intermediate II was a dienone tautomer of the product
(Scheme 4.3). Intermediate III decays slowly and limits the turnover number (k4). The
decay of III occurs concomitantly with re-formation of the HPPD•Fe(II)•HPP charge
transfer complex (Scheme 4.3). The rate constant for this step is slowed further by
solvent deuterons suggesting that protonation of the product is required for dissociation
(12). The evidence obtained suggests that the intermediates observed are not part of a
successive linear sequence, but are instead separated by other transient species that form
and decay rapidly and therefore do not accumulate. Here, we present spectrophotometric
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pre-steady-state analyses for a variant of HPPD in which the catalytic steps that
contribute to the turnover number are chemically and kinetically altered. Identification of
this variant was part of a broad mutagenesis effort to alter hydroxylation regiospecicity
and unveil parts of the catalytic cycle kinetically obscured in the WT enzyme. Conserved
residues predicted from structure to be mechanistically important were targeted for this
study (4,13-16). This included alterations at positions N245, S230 and P243 that are
known specificity and mechanistic determinants. (See chapters 2 & 3)

!

!

121!
4.2 Materials and Methods
Materials. HPP and HG were purchased from Acros Chemicals. Competent BL21(DE3)
Escherichia coli cells were obtained from New England Biolabs. IPTG was from Gold
Biochemicals. Q-Sepharose was from Bio-Rad. Sephacryl S-200 was obtained from
Amersham. Quinolacetate (QAA) was made using the P243T variant described in this
manuscript and purified as previously described (14). All other chemicals, buffers, and
biological media were obtained from Fisher Scientific or Sigma-Aldrich Chemicals and
were of high purity.

Mutagenesis. Mutagenesis was performed using the materials and protocol of the
Stratagene QuikChange Lightning ® kit. pET17b-derived (Novagen) plasmid carrying
the Streptomyces avermitilis HPPD gene (pSAHPPD;(5)) was mutated as previously
described to obtain variant HPPD enzymes in this study (14,17). All variants were
screened for spurious mutations by sequencing the entire dioxygenase genes (Sequetech,
Mountain View CA). Oligonucleotides (including respective reverse complements) used
for mutagenesis are detailed as below:
SAHPPDN245S: GTCAAGTTCCCGATCAGCGAGCCCGCCCTGGCCAAGAAGAAGTCCC
SAHPPDN245A: AAGGTCAAGTTCCCGATCGCTGAGCCCGCCCTCGCCAAG
SAHPPDN245Q: CAAGTTCCCGATCCAGGAGCCCGCCCTGGCCAAGAAGAA
SAHPPDP243T: CTCAAGGTCAAGTTCACGATCAACGAGCCCGCCTTGGCCAAGAAGAAGTCC
SAHPPDS230A: GACATCGCGACCGAGTATTCGGCGCTGATGGCGAAGGTCGTGGC

Expression and Purification. The apo-forms of wild-type and variants of HPPD were
expressed and purified using ammonium sulfate fractionation, anion exchange
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chromatography and size exclusion chromatography according to previously published
methods (5).

Measurement of the Dissociation Constants for the Variant HPPD•Fe(II)•HPP
Complexes. The binding constant for the HPPD•Fe(II)•HPP complex of each variant was
measured according to the methods of Johnson-Winters et al. (5). Each apo-HPPD variant
(180-220 µM) in 20 mM HEPES buffer, pH 7.0 was made anaerobic at 4 °C by
subjecting them to 45 alternating vacuum and argon cycles (a 2 min period was given to
the sample to exchange dissolved gases after each set of three cycles) in a tonometer. A
equivalent concentration of ferrous ammonium sulfate was added from a side arm to the
enzyme solution after anaerobiosis was obtained. Anaerobic HPP solutions of various
concentrations were prepared by sparging argon through each for 10 min just prior
mixing them with holo-enzyme solution. Both, the enzyme containing tonometer and
substrate syringe were mounted on a Hitech model-SF61-DX2 stopped-flow
spectrophotometer. For each HPP concentrations, the enzyme spectrum was monitored
until no further change was observed. This absorbance spectrum (300-700 nm) provided
a measure of the fractional enzyme-substrate complex concentration ([HPPD•HPP])
obtained for each HPP concentration, which was plotted against total HPP concentration.
These data were fit to equation 1 to calculate Kd HPP and the concentration of the available
binding sites.

equation 1. [HPPD•HPP] = { Kd HPP + [HPP] + [HPPD] − ((Kd HPP + [HPP] + [HPPD])2
−4 [HPP][HPPD])1/2}/2
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Stopped-Flow Measurements. The HPPD•Fe(II)•HPP complex was prepared using the
previously described methods of Johnson-Winters et al. (5). A solution of each HPPD
variant (N245Q and P243T) (400-450 µM) was added to a tonometer and saturating
concentrations of HPP (calculated from a previously measured HPPD•Fe(II)•HPP
complex dissociation constant for each variant) were added to a side arm and
concentrations of ferrous sulfate sufficient to ensure 1:1 concentration equivalency with
the apo-HPPD was placed in a second side arm. This vessel was then used to obtain
anaerobiosis using the methods described above. After anaerobiosis was achieved, the
apoenzyme was mixed initially with Fe(II) from one sidearm and then with HPP from the
other sidearm. The complex formed in this way exhibited a characteristic color (unique to
each variant) due to a metal to α-keto acid ligand charge transfer band at around 500 nm.
a) Single Turnover Reactions. An anaerobic N245Q•Fe(II)•HPP complex was made as
described above (5). 800 µM apoN245Q HPPD was combined with 850 µM Fe(II), and
2640 µM HPP. The reaction of this complex with limiting dioxygen concentration was
observed spectrophotometrically using a HiTech Scientific (now TGK) stopped-flow
spectrophotomter using both photomultiplier and photodiode array detection. Data were
collected with logarithmic time spacing and were analyzed using Kinetic Studio (TgK
Scientific) the Specfit/32 Global Analysis System (SpecSoft Inc) and fit to the four-step
model depicted in Scheme 4.2 to determine rate constants for individual steps.
b) Oxygen Dependence of N245Q•Fe(II)•HPP Complex. The reaction of N245Q variant
HPPD•Fe(II)•HPP complex (40 µM final) with molecular oxygen was observed at 380
nm. The ternary complex was made anaerobic as described above and then titrated
against a range of dioxygen concentrations (200 – 1000 µM final).
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4.3 Results
Expression and Purification of the HPPD Variants. All HPPD variants mentioned in
this study were expressed and purified using published methods for the wild type
enzymes (5,17,18). All the variants studied yielded active enzymes and the yield was
comparable to the wild-type enzyme.

Dissociation Constant for the Variant HPPD•Fe(II)•HPP Complexes. Each HPPD
variant was titrated against HPP under anaerobic conditions to determine the dissociation
constant. The physical signal for the association of HPP was the accumulation of weak
metal-to-ligand charge transfer absorption bands that arise in the HPPD•Fe(II)•HPP
complex (∼500 nm). The absorption maximum of these transitions varied for each variant.
Figure 4.2A depicts a difference spectra from the titration of S230A•Fe(II) against varied
HPP concentrations. Figure 4.2B and C depict binding isotherms for N245Q, S230A, and
N245A, P243T respectively. The Kd HPP for each variant from binding isotherms were
determined by fitting the data to equation 1 (Table 4.1).

Table 4.1 Substrate (HPP) Binding in Wild-type and Variants of HPPD

a

!

Variant

Kd HPP (µM)

Wild-type HPPD

90 ± 3a

N245Q

78 ± 23

N245A

172 ± 56

N245S

118 ± 22

S230A

107 ± 41

P243T

269 ± 39

Dissociation constant for wild-type was taken from reference 5.
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Figure 4.2 Binding isotherms for HPPD Variants at 4 °C. (A) An example difference
spectra from the titration of 107 µM holo-S230A with HPP (48 – 2960 µM). (B) 220 µM
N245Q•Fe(II) ( ) titrated against HPP (12.5 – 1000 µM) and 180 µM S230A•Fe(II) (O)
titrated against HPP (48 – 2960 µM) in 20mM HEPES, pH 7.0. The data were fit to
equation 1. (C) 200 µM N245A•Fe(II) ( ) titrated against HPP (12.5 – 3200 µM) and
180 µM P243T•Fe(II) (O) titrated against HPP (12.5 – 1000 µM) in 20mM HEPES, pH
7.0. The data were fit to equation 1.
The dissociation constant for wild-type HPPD•Fe(II)•HPP complex is 90 ± 3
µM (5). All the variants studied had a dissociation constant very similar to the wild-type
HPPD with even the most pronounced difference, that for P243T, exhibiting only a threefold decrease in affinity. This suggests that the residues altered have little direct energetic
contribution to the HPPD•Fe(II)•HPP complex.
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Figure 4.3 Kinetic data and fit for N245Q using pseudo-first-order reactant
stoicheometry in the presence of saturating HPP (12). The reaction of the
N245Q•Fe(II)•HPP complex (800 µM N245Q, 850 µM Fe(II) and 2.64 mM HPP) with
160 µM molecular oxygen at pH 7.0 and 4 °C can be seen in the figure. (A) 380 nm
(black) stopped-flow trace observed with the fit (red) to the model described in Scheme
4.2. (B) Concentration profiles of species observed in a single turnover, where
intermediate I is depicted in green, intermediate II in violet, intermediate III in orange.
(Enzyme-substrate complex has been omitted due to its higher concentration.) (C)
Deconvoluted intermediate spectra: N245Q•Fe(II)•HPP (blue), intermediate I (green),
intermediate II (violet), intermediate III (orange). (D) N245Q•Fe(II)•HPP complex (40
µM final) titrated against various oxygen concentrations (200 – 1000 µM) increasing
from right to left and observed at 380 nm, in 20 mM HEPES, pH 7.0 at 4 °C.
Single Turnover Reactions. Single turnover reaction kinetics indicated that only the
N245Q variant exhibited intermediate accumulation. Limiting oxygen with respect to
enzyme-substrate complex concentration allowed the establishment of approximate
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pseudo-first-order conditions and confined the number of turnovers to one (for a 20%
fraction of the enzyme sample). Figure 4.1 and Figure 4.3 show the deconvoluted
intermediate spectra, intermediate concentration profiles and absorbance traces of wildtype HPPD and N245Q variant.
From the fit of the trace depicted in Figure 4.3A, the rate constants derived are; k1
= 1 × 103 M-1 s-1, k2 = 0.14 s-1, k3 = 0.05 s-1, and k4 = 0.002 s-1 indicating three
accumulating intermediates and assuming that the first event has a first order dioxygen
dependence. However, the trace depicted in Figure 4.3A did not include the end of
turnover that, based on the half-life of the slowest rate constant, would have occurred at
approximately 2,500 seconds. The last rate constant (k4) is significantly slower than the
measured turnover number for this variant, which is 0.01 s-1 at 4 °C. This phenomenon
will be discussed later in this chapter. Figure 4.1B shows the accumulation of three
catalytic intermediates in wild-type HPPD. Both the rate constants and the spectra
derived from the accumulation of the three intermediates in N245Q variant differ from
those observed with WT HPPD. The comparison of the intermediate I (green) spectra
from wild-type HPPD (Figure 4.1C) (12) and N245Q variant (Figure 4.3C), suggests a
unique first transient in each enzyme. While in wild-type HPPD, intermediate I absorbs
maximum at 370 and 480 nm with extinction coefficients of 2400 and 700 M-1 cm-1
respectively (12), for the N245Q variant, intermediate I has absorption maxima of ∼440
nm and ∼550 nm with extinction coefficients of 550 and 330 M-1 cm-1 respectively.
Qualitatively, intermediate I has features similar to N245Q•Fe(II)•HPP complex (tzero
spectrum) but with more intense extinction coefficients. Intermediate II is the most
strongly absorbing species with shoulders at 435 and 580 nm and respective extinction
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coefficients of 670 and 370 M-1 cm-1. This intermediate does not show absorption
transitions that resemble any of the transients that are observed to accumulate in wildtype HPPD (Figure 4.1C). Intermediate III is the least intense of all species observed.
This intermediate has shoulders at 445 and 560 nm with extinction coefficients of 400
and 200 M-1 cm-1 respectively. Intermediate III exhibits features very similar to
intermediate II (Figure 4.1C), however, because we failed to observe an end of turnover
for this variant, we only observed a fraction of the re-formation of the HPPD•Fe(II)•HPP
charge-transfer transitions that arise with the dissociation of the product. The lack of data
describing the latter stages of catalysis undermines the singular value decomposition
algorithm’s capacity to deconvolute the dataset. However, it is immediately apparent that
the N245Q variant is dramatically slowed in turnover suggesting that the N245 position
has critical participation at multiple stages of catalysis.
Figure 4.3D depicts oxygen dependence of the approach to the steady state for the
reaction of N245Q. It is apparent that for WT HPPD and HMS the addition of dioxygen
has been shown to be a second order reaction that does not include complexation (5,19).
Figure 4.3D depicts traces for the reaction of N245Q with various dioxygen
concentrations. It is visible that there is dioxygen dependence but the amplitude of the
phase associated with dioxygen addition is very small relative to signals from
turnoversuch that the dioxygen dependence cannot be determined definitively . The rate
constants derived from single turnover reactions of N245Q are all dramatically slower
than WT HPPD. The initial rate constant in which the enzyme reacts with dioxygen is at
least two orders of magnitude slower than that observed in WT HPPD. This value is now
only one order faster than autooxidation observed in the holoenzyme (Streptomyces
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avermitilis HPPD (39 M-1 s-1) (5), Arabidopsis thaliana HPPD (46 M-1 s-1) (20) and
Amycolatopsis orientalis HMS (34 M-1 s-1) (19)). This indicates that for this variant k1 is
much less catalytically enhanced and is evidence that N245 plays an important role in
substrate recognition and substrate as an effector for the dioxygen reaction.

4.4 Discussion
For wild-type HPPD, three intermediates were observed in pseudo-first order
single turnover reactions (12). Johnson-winters et al, with the aid of kinetic isotope
effects and fluorescence techniques were able to deduce the identity of the product
complex and make reasonable speculation of the identity of the second intermediate as
the dienone product tautomer complex. The primary objective of this study was to
prepare and examine HPPD variants in the hope of unveiling new mechanistic details
from single turnover studies and possibly identify variants more amenable to rapid freeze
quench for the spectroscopic identification of transients. Residues implicated as key to
hydroxylation regiospecificity were targeted. P243, N245 and S230 have been implicated
as important positions for HPPD catalysis and hydroxylation regiospecificity. The latter
two of these residues are thought to make unique hydrogen bonding arrangements with
the substrate/intermediate phenolic hydroxyl group throughout catalysis (13).
Interestingly, the dissociation constants measured for variants at these positions exhibited
no pronounced difference from that measured for the wild-type HPPD. The primary
observation was that for N245Q high accumulation of a first and second intermediate
could be observed at greatly prolonged times suggesting that this variant is a candidate
for intermediate trapping studies.
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The N245Q variant was the only variant that exhibited significant intermediate
accumulation. This variant accumulated three intermediates in single turnover reactions.
All three intermediates have unique absorption transitions with respect to the
intermediates observed with the wild-type HPPD (Figure 4.1C and 4.3C). This plausibly
suggests that new intermediates accumulate in single turnover reactions of this variant.
Intermediate I depicts a maximum accumulation of 67% at 2.8 s, intermediate II
accumulated maximum to 56% at 13 s, while intermediate III had maximum
accumulation of 92% at 85 s. These prolonged time points and high fractional
accumulations make this variant an excellent candidate for a rapid freeze quench for the
spectroscopic identification of new intermediates for the HPPD reaction coordinate.
However, this may not allow us to observe the native chemistry as the, N245Q variant
shows a different product profile relative to the wild-type HPPD. This variant makes
three different products, 52 % homogentisate (HG, native product), 45 % 4hydroxyphenylacetate (HPA, singly oxygenated and decarboxylated product) and 3 %
quinolacetate (QAA, doubly oxygenated anddecarboxylated but without substituent
migration). As such the steps that occur after the formation of the hydroxylating
intermediate bifurcate (roughly evenly) along unique paths diminishing the actual
accumulation of catalytic species involved in the native chemistry that forms HG. With
the production of 45% of HPA, ∼100% of the enzyme is able to accomplish the
decarboxylation half-reaction that yields the putative ferryl-oxo species. The reactive
ferry-oxo species can potentially hydroxylate any proximal active site residue. This selfhydroxylation phenomenon has been observed earlier with other α-KAOs (21-24). In
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order to establish true fractional accumulations the fate of ∼25% of the oxygen atoms
must be accounted for.
The dramatically slowed rate constant for the addition of dioxygen indirectly hints
at the plausible function of this residue in orienting the substrate HPP in the active site. In
prior work it has been shown that flattening of the α-keto acid of HPP in the
HPPD•Fe(II)•HPP complex is critical for heightened dioxygen reactivity (24-26). The
~100-fold slower rate constant for dioxygen addition observed with this variant may be a
consequence of an inability to define this reactive conformation at the α-keto acid moiety
in the substrate complex. However, this assertion needs to be studied in depth using CD
and MCD spectroscopies. The observation that the last rate constant observed in single
turnover experiments is significantly slower than the measured turnover number, suggests
that in the pre-steady state we observed the slower of two linked catalytic cycles that both
regenerate active enzyme(Scheme 4.4). One cycle forms HG and is slow while the other
forms HPA from a abortive process associated with more rapid steps that occurs in one
half of turnovers. This phenomenon would yield a turnover number based solely on
dioxygen consumption that is roughly equivalent to one half of the rate constant observed
for the step that bifurcates. In this case approximately equal to one half of k2 (0.14 s-1).
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Scheme 4.4 The kinetic model for a single catalytic cycle of N245Q
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Figure 4.4 Deconvoluted intermediate spectra for HMS and N245Q HPPD. On the left,
the intermediate spectra from the single turnover reaction of HMS are demonstrated (This
figure is taken from reference (19)). For HMS, intermediate I is depicted in green,
intermediate II is orange, intermediate III is violet and HMS•Fe(II)•HPP complex is pink.
On the right, the intermediate spectra from the single turnover reaction of N245Q HPPD
are demonstrated. For N245Q, intermediate I is depicted in green, intermediate II is
orange, intermediate III is violet and HMS•Fe(II)•HPP complex is pink.
The deconvoluted intermediate spectra from N245Q HPPD were also compared to
those obtained from the single-turover reactions of hydroxymandelate synthase (HMS)
(19), the sister enzyme of HPPD (see chapters 1,2 &3). This comparison exhibited one
striking similarity among the deconvoluted spectra observed (Figure 4.4). The spectral
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comparison between the intermediate I from HMS and intermediate II from N245Q,
suggested a common intermediate that occurs in the catalytic cycle of both enzymes.
However, intermediates I and III for N245Q did not show any similarities to the first and
third intermediate in HMS. Interestingly, N245Q HPPD does not form HMA
(hydroxymandelate-product of HMS reaction), and intermediate II for N245Q is similar
to the intermediate I in HMS. This qualitatively suggests that intermediate II arises prior
to or is the ferryl-oxo species that is common to both enzymes. For N245Q, the decay of
intermediate III is concomitant with the re-formation of the fraction of the charge-transfer
complex.

Figure 4.5 N245 position in HPPD wild-type and variants. N245 position in the wildtype has been taken from (13). N245 variants, N245Q and N245S have been generated
with PyMOL using wild-type structure with substrate modeled into the active site (13).
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Scheme 4.5 Alternative products in the variants of N245 position in HPPD. (A) The
available trajectory for the electron movement in the substrate aromatic ring for N245
variants in the absence of native hydrogen bond. (B) Native reaction in the presence of
the hydrogen bond between the substrate hydroxyl group and N245 position in HPPD.
As predicted from the structure of wild-type HPPD, N245 is thought to make a
hydrogen-bond with the substrate hydroxyl group. We have observed alternate products
in N245 variants, N245S (14) and N245Q (Chapter 2) (17) (Figure 4.5). N245S forms
∼80% QAA, whereas N245Q forms ∼3% QAA in a mixture of total products. One
hypothesis for the formation of these alternative products is that, the native hydrogen
bond with N245 residue abolishes the movement of the electrons back into the substrate
aromatic ring from the phenol hydroxyl group (Scheme 4.5B) and thus prevents the
formation of QAA. In N245 variants, the absence of or an improperly formed hydrogenbond would permit electrons from the Ph-O-H bond to delocalize into the aromatic ring
for a fraction of total turnover forming QAA. This fraction would be higher in the
complete absence of a hydrogen-bond as seen in N245S, whereas it would be lower in the
presence of an improperly formed hydrogen-bond which could be the case with N245Q.
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Collectively these data suggests that N245 plays unique important roles at multiple stages
of catalysis; initially promoting dioxygen reactivity in the HPPD•Fe(II)•HPP complex
and then limiting the chemical outcomes by localizing the phenol hydroxyl electrons
prior to the NIH shift step.
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